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CHAPTER 1
REVIEW OF LITERATURE

Introduction

Developmental programming refers to the phenomenon in which maternal
metabolic state, physiological traits, or environmental factors influence fetal growth and
development that leads to permanent changes in the physiology of a postnatal animal
(Barker et al., 1997). These factors can be gynecological immaturity, nutritional stress,
climate, and genetic, among others. Failure of any one maternal system to successfully
support the fetus during gestation can lead to poor physical, physiological, and
psychological development (Barker et al., 1997).
The placenta is a transient fetal organ that is the most important factor in allowing
a fetus to develop to term as well as ensuring proper development. The placenta is
responsible for nutrient and gas exchange as well as hormone production; an abnormality
in either of those areas can cause detrimental effects on the fetus that can persist later in
life (Jansson et al., 2000b).
Developmental programming can be traced through epidemiology, where a strong
correlation can be made between low birth weight or maldevelopment with increased
risks of physical or mental ailments such as obesity and behavioral problems (Barker
2004). However, developmental programming is not always accompanied by decreased
birth weight. For example, dams that undergo stress during the beginning of gestation but
not the end are likely to produce a normal birth weight offspring that may still suffer from
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poor growth and metabolic issues because of the stress early in pregnancy (Barker 2004;
Ford et al., 2007; Vonnahme et al., 2007; Dong et al., 2008).
In 1992, Hales and Barker presented the “Thrifty Phenotype Hypothesis.” This
hypothesis suggests that Type 2 diabetes mellitus and other metabolic disorders have a
strong correlation to the maternal environment. The Thrifty Phenotype hypothesis states
that fetal malnutrition can be a result of either maternal malnutrition or placental
dysfunction. In response to its poor nutrition status, the fetus adopts several coping
mechanisms. Firstly, the fetus partitions nutrients to the development of the brain and
heart at the expense of other organs, such as the skeletal system and musculature.
Secondly, the fetus alters its metabolic physiology to prepare for malnutrition during
postnatal life. Unfortunately, if the postnatal animal has adequate or above adequate
nutrition, this can cause the animal to become obese, consequently leading to diabetes
(glucose/insulin dysregulation) and hypertension (Ozanne et al., 2002). Ewes fed a 50%
global nutrient restriction diet during d 28 – d 78 of gestation had female offspring who
showed increased insulin secretion and altered glucose metabolism (George et al., 2012),
which is consistent with efficient energy acquisition and storage (Hales et al., 2001) as
well as predisposition for metabolic diseases later in life (Hales et al., 2003). The
differences in glucose metabolism correspond to a greater capacity for glucose
production from the liver and an increased expression of phosphoenolpyruvate
carboxykinase (PEPCK) (George et al., 2012), the enzyme that catalyzes gluconeogenesis
(Pilkis et al., 1992). Additionally, the lack of change in glucose-6-phosphatase (G6P)
expression, the liver enzyme which catalyzes glucose-6-phosphate to glucose, suggests
that new glucose-6-phosphate from increased gluconeogenesis could be directed toward
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glycogen synthesis and storage rather than converted to glucose, essentially increasing
glycogen storage and subsequent weight gain (George et al., 2012). Offspring from
nutrient restricted dams gain more weight per unit feed when fed a high quality ad
libitum diet, suggesting a higher efficiency for body tissue deposition and the gene
expression of PEPCK and G6P could explain this efficiency (George et al., 2012). This
higher efficiency and early programming may be the cause of people gaining weight
versus remaining lean despite similar lifestyles (George et al., 2012).
In 1995, Barker presented a similar but different theory, “The Barker
Hypothesis”, which asserts that fetuses that undergo stress during gestation will most
likely have physical, physiological, or psychological defects later in life. The best study
of this phenomenon is the Dutch Hungry Winter. The population of Nazi occupied
Holland was subjected to a severe famine and the offspring of women that were pregnant
were tracked and are now in their early 70’s. Multiple generations later, observations of
the population have revealed long-term detrimental health effects such as heart disease,
obesity, and diabetes (Stein et al., 1995). The Barker Hypothesis also suggests that birth
weight and cardiovascular disease have an inverse relationship – as birth weight
decreases, the incidence of cardiovascular disease increase.
Developmental programming likely has significant effects on livestock
production. Breeding of young animals can cause stress, especially if the animal is
immature, as metabolic energy is being used for growth and development of the dam as
well as the fetus. Furthermore, lactation causes an energy competition between the
developing fetus and production (Knight et al., 2001). In beef cattle, animals that
experience stress in-utero can have reduced skeletal growth, which can affect carcass
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merit and meat production (Greenwood et al., 2005). This could be especially
problematic in heifers if they are used as breeding stock. Intrauterine growth retardation
(IUGR) is defined as any stressor on an animal that causes reduced fetal growth during
gestation; IUGR can be environmental or physiological, occur at any point during
gestation, and has permanent negative effects on the offspring’s physiology and
development (Baker et al., 1969). These negative effects include decreased growth rate,
decreased meat and body composition, and reproductive performance in swine and ewes
(Baker et al., 1969; Pond et al., 1969; Wallace et al., 2005). Not only is the particular
offspring affected, but also IUGR can have transgenerational effects, making the
inclusion of an animal affected by IUGR detrimental to future generations (Anderson et
al., 2006; Long et al., 2013b; Long et al., 2013c). The objective of this review is to
consider aspects of fetal and placental development, both normal and abnormal.

Maternal

Normal adaptations to pregnancy in bovine

After ovulation, the follicular cells reorganize to form the corpus luteum (CL) on
the ovary. The corpus luteum produces progesterone (P4), which is required to maintain
pregnancy. After fertilization at the ampullary-isthmus junction in the oviduct at d 0-1 (d
0 = ovulation), the zygote begins cellular division and moves through the oviduct towards
the uterus (Senger 2005). Around d 4-5, the embryo is approximately 30 cells and moves
into the uterine body. Around d 9-10, the embryo is now considered a blastocyst and

	
   4	
  

“hatches”, releasing the intracellular mass (ICM) and trophectoderm cells, which form
the placental membranes (Senger 2005). Around d 16-17, elongation of the embryo
provides for the production of interferon-τ (IFN- τ), the pregnancy recognition signal for
ruminants (Spencer et al., 1996; Spencer et al., 2004; Spencer et al., 2007; Bazar et al.,
2010). IFN- τ is also required for adhesion (Spencer et al., 2007). After adhesion,
complete around d 30-35 (Senger 2005), the placenta and placentomes begin to develop
(Spencer et al., 2007). Near the end of bovine gestation, progesterone in the corpus
luteum declines (Erb et al., 1968), the corpus luteal cells begins to degenerate
(Hutchinson, 1962), and surrounding capillaries around the corpus luteum begin to
decrease in number and size (Hutchinson 1962). However, systemic progesterone
concentrations remain constant, suggesting presence of progesterone production outside
the ovary, most likely the placenta (Gomes et al., 1965; Stabenfeldt et al., 1970) during
the last 100 days of pregnancy.
Pregnancy is a delicate condition and subjects the dam to metabolic stress.
Nutritional demands are increased to meet the demands of the dam as well as the fetus.
These demands are increased even more when the dam is young and still growing
(Durnin 1987). As nutritional demands are increased, the condition leads to an increased
need for gastrointestinal hormones and gastrointestinal mass (Faulkner et al., 1988).
Gastric inhibitory polypeptide (GIP) is a key hormone in regulation of glucose
metabolism and will therefore change during pregnancy as the pregnant animal’s
requirements change (Irwin et al., 2010). Pregnancy is associated with increased insulin
resistance, generally associated with a decrease in adiponectin (Li et al., 2009), and
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increased insulin demand; it is possible that GIP has a role in altered glucose homeostasis
(Retnakaran et al., 2010).
In ruminant digestion, starches are fermented into volatile fatty acids (VFAs) and
therefore the animal relies mostly on gluconeogenesis in the liver, and occasionally
kidneys, to provide glucose. Glucose requirements are quadrupled in high producing
dairy cattle and doubled in twin bearing ewes compared with non-lactating, non-pregnant
animals (Bell et al., 1997). Propionate (VFA produced by pre-gastric fermentation) is the
primary precursor for hepatic gluconeogenesis. The concentration of propionate produced
is directly related to dietary intake of starch substrates that can be fermented by
amylolytic bacteria in the rumen (Peters et al., 1983; France et al., 1993). Without
propionate, the liver uses lactate, certain amino acids, or glycerol as a gluconeogenesis
substrate (Brockman 1993). Throughout the ruminant animal, some tissues such as
muscle and adipose that require glucose for non-oxidative functions can produce glucose
through substitute VFAs and derivative ketoacids without propionate in order to meet
increased glucose demands (Petterson et al., 1993). Beyond this, ruminants are also able
to utilize acetate as an oxidative fuel (Lindsay 1978) and free fatty acids (FFAs) if the
energy requirements of the animal require it to do so (Bird et al., 1981; Pethick et al.,
1981). The placenta is a major contributor to increased glucose demands in the pregnant
animal (Bell et al., 1986). Glucose is transported from the maternal environment to the
placenta by facilitated diffusion (Widas 1952; Simmons et al., 1979) through GLUT 1
and GLUT3 transporters and the expression of these transporters increase between mid
and late gestation (Ehrhardt et al., 1997).
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Gluconeogenesis in the fetus is controlled by PEPCK (PCK1 gene), glucose-6phosphatase (G6Pase, G6P gene), and fructose-1, 6-bisphosphatase and is not activated
until just prior to parturition (Hanson et al., 1997). Increases in glucagon, cortisol, and
catecholamines activate the glycogenolytic and gluconeogenic pathway (Pilkis et al.,
1992; Fowden et al., 1993; Hanson et al., 1997). Insulin acts as a gene suppressor that
prevents gluconeogenesis from activating too soon (Edgerton et al., 2009). Fetuses with
IUGR have a subsequent shift in fetal metabolism, decreasing basal insulin
concentrations and increasing regulatory hormones, therefore increasing gluconeogenic
gene expression and causing gluconeogenesis to activate sooner than normal (Limesand
et al., 2006; Limesand et al., 2007; Thorn et al., 2011). In a well-fed dam, almost 100%
of the glucose utilized by the fetus comes from maternal glucose (Hay et al., 1984). In an
underfed dam, the fetus then relies on endogenous hepatic gluconeogenesis through use
of amino acids of substrates (Dalinghaus et al., 1991). Transport of amino acids from
dam to fetus are not impaired by maternal nutrition (Lemons et al., 1983), but the use of
amino acids for glucose decreases protein synthesis, impairing muscle development in the
fetus (Krishnamurti et al., 1984). The previously mentioned Baggs ewe study (Jobgen et
al., 2007) suggests that through selection, it is possible for the dam to compensate during
nutrient restriction and increase placental efficiency when considering amino acid
transport.

Effects of age
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A nutrient restriction (86.7% metabolizable protein, 68.1% NEm) study in cattle
showed marked differences in fetal development when comparing NR IUGR (nutrient
restricted intrauterine growth restriction) and NR non-IUGR (Long et al., 2009). The NR
IUGR group was, on average, 18 months younger than the NR non-IUGR group. The NR
IUGR group showed a decreased fetal weight, decreased empty carcass weight, and
decreased abdominal circumference, and an increase in heart ventricle weight and septum
thickness. They observed a decrease in liver, lung, heart, and brain weight, but when
corrected for decreased fetal weight, the changes were not significantly different than the
non-IUGR group. They also reported a decrease in cotyledonary weight, caruncle weight,
and plasma glucose (Long et al., 2009). It has been suggested that younger animals are
perhaps more susceptible to nutrient restriction because cattle grow until about 4 years of
age (Morrow et al., 1978; Johnson et al., 1990; Arango et al., 2002), though the growth
rate is very low. Furthermore, with the decreased cotyledonary growth, perhaps the IUGR
group was unable to transport as much glucose to the fetus, even if it had been available
(Long et al., 2009).

Fetus

Normal fetal development

In a study done by Prior and Laster (1979) on bovine fetal development, it was
shown that initial fetal growth rate is 7.4%/day and the rate declines by 0.125% each day
of gestation. A previous study by Ferrell et al. (1976) showed a 5.1%/day initial growth
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rate with a decrease of 0.007% for each day of gestation. Fetal weight, protein, fat, ash
content, DNA, RNA, protein/DNA ratios (cell enlargement: cell division), and
RNA/DNA (hypertrophy) were shown to increase exponentially with each day of
gestation (Prior et al., 1979). Fetal weight gain reaches its peak at day 232 of gestation
while protein growth peaks at 242.5 days of gestation (Prior et al., 1979). Eley et al.
(1978) reported that peak growth rate for the bovine fetus was at 230 days of gestation,
but the study done by Prior and Laster (1979) showed an increased weight gain of
131g/day. Ash accretion levels peaked at day 249.5, though ash content, like protein, did
not maximize until after expected parturition date. DNA reached a maximum at 217.5
days of gestation. Fat deposition and RNA accretion, along with ash and protein content,
did not peak until after expected parturition date (Prior et al., 1979).
After embryo elongation and maternal recognition, bovine fetal growth is
primarily due to hyperplasia, the increase in number of cells, while each individual cell
maintains a consistent size. Later in gestation, fetal development involves hypertrophy
(increase individual cell size) as well as hyperplasia, during the last third of gestation,
only hypertrophy contributes to fetal development (Winick et al., 1965). However, in the
Prior study (1979), it was shown the hyperplasia occurs throughout gestation in the
bovine by observing increases in DNA content through the entirety of gestation.
Hyperplasia contributes to DNA increases while hypertrophy helps increase fetal weight
through increased protein/DNA and RNA/DNA ratios (Winick et al., 1965). Growth
retardation at the level of hyperplasia often lead to permanent detrimental effects, while
retardation at the level of hypertrophy can often be overcome; therefore, as hyperplasia
occurs throughout bovine gestation, any retardation of fetal growth during gestation could
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have a long-term detrimental effect on the fetus. However, while hyperplasia does occur
during the entire gestation, its affects are less critical as the fetus ages, making growth
retardation less of an issue at the end of gestation. If a dam undergoes nutrient restriction
during late gestation, then the fetus will most likely be subjected to decreased mechanical
growth and possibly a few postnatal issues such as decreased average daily gain, because
by late gestation the fetus is already mostly developed and only lacks in physical size
(Prior et al., 1979). A dam that undergoes nutrient restriction during the first third or
middle third of gestation can subject the fetus to an actual detriment in development, as
cells are still dividing and determining into specific organ systems and functions (Prior et
al., 1979). Tissues and organs develop at different speeds and time during gestation and
as skeletal muscle is one of the last tissue groups to be effected by hyperplasia, growth
retardation near the end of gestation is most likely to cause a detrimental effect on
skeletal muscle (Prior et al., 1979). However, more recent studies have shown that 50%
maternal nutrient restriction during early gestation (d 30 – d 70) in ewes results in lambs
with increased fast twitch fibers and increased muscle fiber diameters (Daniel et al.,
2007). Furthermore, as skeletal muscle growth is considered less important than other
organ systems (i.e., heart or brain); the musculature is especially vulnerable to nutrient
restriction. Fetal muscle maturity proceeds through the development of primary
myofibers and then secondary myofibers, which arise from previously undifferentiated
precursor cells. Limited nutrients can slow the division of precursor cells, leading to
overall fewer muscle fibers (Zhu et al., 2006).

Adaptions to IUGR
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Fetuses that undergo intrauterine growth restriction (IUGR) often exhibit
“symmetrical” or “asymmetrical” growth patterns. Symmetrical growth restriction is
often caused by a genetic disorder or infection that affects the fetus during gestation as
opposed to a sub-par maternal environment (Anthony et al., 2003). A symmetrical growth
restriction is often categorized by a size reduction in all organs and tissues similarly.
Conversely, an asymmetrical growth pattern shows a reduction in some organs or
structures but not all (Anthony et al., 2003). Asymmetrical growth is linked to maternal
and placental factors as opposed to a genetic predisposition. This suggests that the fetus
prioritizes nutrients and blood flow to the organs and structures that are most pertinent to
development (Anthony et al., 2003).
When exposed to a lack of nutrients, whether from maternal diet or placental
inefficiency, the fetus can adjust its endocrine environment (Barker 1998). One of the
adjustments that can occur because of a nutrient deficient environment is an increase in
glucocorticoids during late gestation. This increase in glucocorticoids can increase the
development of some organs (Anthony et al., 2003). However, this excess of
glucocorticoids consequently causes decreased fetal weight, decreased placental size, and
long-term effects such as hypertension and hyperglycemia (Jobe et al., 1998; Moss et al.,
2001; Seckl 2001; Jensen et al., 2002).
Several studies have shown that uterine capacity has an impact on fetal growth
and birth weight. When a fetus with a genetic disposition for increased (or large) size is
moved to a dam with a smaller uterine capacity, the birth weight is lower than expected,
and vice versa for a fetus with a genetic disposition to a decreased (or small) size
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(Dickinson et al., 1962; Ferrell 1991; Allen et al., 2002). This suggests some factor in the
fetus or placenta that alters fetal size while in utero. In an ovine surgical uterine capacity
model by Meyer and colleagues, it was shown that fetuses with a restricted capacity had
51% fewer placentomes and a 31% reduction in placentomal weight when compared to
non restricted (2010b). At day 130 of gestation, space restricted fetuses showed a
decrease in weight, reduced crown-rump, abdominal and thoracic girth, as well as
decreased fetal heart, kidney, liver, spleen, and thymus weights as compared to non space
restricted fetuses, while lung and brain weights were unaffected (Meyer et al., 2010a).
The placental efficiency of restricted fetuses increased, but elevated levels of fetal arterial
creatinine, blood urea nitrogen, and cholesterol suggests that placental transport capacity
had decreased (Meyer et al., 2010a).

Placenta

Histomorphology and Ultrastructure

The placenta is a transient organ that is crucial to fetal growth and development.
The placenta allows for nutrient and gas exchange to the developing conceptus (Ramsey
1982) and hormone production that can influence both fetal and maternal physiology
(Gey et al., 1938; Josimovich and MacLearn, 1962; Kaplan and Grumbach, 1964). The
development and function of the placenta can be heavily impacted by environmental
factors and nutrition (Arnett et al., 1997; Constancia et al., 2002).
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The bovine placentome consists of both maternal and fetal tissues. The maternal
tissues of the placentome consist of the caruncular stalk, maintaining the basal plate and
septae (Leiser et al., 1997). The fetal tissues form convex cotyledons with the chorionic
plate covering the maternal tissues. Villous “trees” radiate out from the chorionic plate
towards the maternal tissues, connecting the maternal and fetal tissues like Velcro. Each
villous “tree” contains a single artery from the allantochorionic arterial system, which
branch off into arterioles and capillaries along the tree. Placentomes cluster together
nearest where the fetus adheres at the beginning of gestation. These placentomes are
larger and have the most developed vasculature. Placentomes located elsewhere along the
placenta are smaller and less developed, called “accessory placentomes” (Leiser et al.,
1997). At day 30 of gestation, the bovine placentomes are small (20-40um wide),
rounded, and either flat or slightly raised. Within a few days (day 33), the placentomes
are all visibly raised and begin to develop visible villi and crypts for association with the
fetal tissues. By day 42, the villi 6 times longer than as on day 33 and include secondary
branching. This increase in complexity causes a tighter association with fetal tissues to
provide adequate exchange between the maternal and fetal environment. Throughout
gestation, the placentome continues to increase in size and complexity (King et al., 1979).
Trophoblasts form the outer cell layer of the blastocyst and interaction with the
endometrium forms placental connections between the developing embryo and uterine
walls. These connections serve as transport of nutrients and gas from the maternal to the
fetal circulation (Wimsatt 1950). Two types of these trophoblasts have phagocytic action.
One group of the phagocytic trophoblasts is located toward the fetus between the bases of
the cotyledons, where they target maternal erythrocytes that are caught between the
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endometrial and chorionallantois tissues. The other group of trophoblasts is located near
the openings of the endometrial glands in the chorionallantois. These trophoblasts target
uterine milk produced by the endometrial glands. Trophoblasts have both an endocrine
and paracrine function, producing hormones such as progesterone (Reimers et al., 1985),
bovine placental lactogen (bPL) (Bolander et al., 1975), pregnancy associated
glycoproteins (bPAG-1, bPAG-2, bPAG-3) (Sasser et al., 1986), and transforming growth
factor beta (Munson et al., 1996) required for fetal development and maternal
maintenance as well as expressing receptors for specific hormones, specifically
progesterone (Schlafer al., 2000). In ruminants, one subpopulation of trophoblasts
diverges into villous structures. They are organized in clusters throughout the placenta
forming cotyledons (Wooding et al., 1994). Another population of cells in placenta is
fetal macrophages, deriving from chorionic mesenchyme or fetal bone marrow derived
monocytes. The cells assist in producing cytokines and antigen presentation and are
important in fetal development (Schlafer et al., 2000).

Vasculogenesis

Adequate blood flow between the maternal environment and the developing fetus
is critically important for successful fetal development as the blood flow has a direct
impact on nutrient and waste exchange. Uterine and umbilical blood flow is centered on
correct vascularization of the placenta. In the developing fetus, organs and tissues with a
higher metabolic activity receive the majority of the blood and therefore the majority of
the nutrients available. While the fetus experiences most of its mechanical growth during
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the last trimester, the placenta undergoes the majority of its growth and development
during the first two-thirds of gestation (Ferrell et al., 1976), though its structure and
cellular component change throughout gestation (Kappes et al., 1992). Vonnahme and
Ford showed that in some species of pigs, vasculogenesis continues to increase markedly
during the end of gestation, increasing placental efficiency (2004). Lack of placental
blood flow during the last trimester of human pregnancies has resulted in intrauterine
growth restriction. Furthermore, decreased blood flow correlates with a high-risk
pregnancy and inhibited fetal growth (Haggarty et al., 2002). During the last half of
gestation, vascular growth on the fetal side of the placenta exceeds that of the maternal
side in order to support the increased growth of the fetus.

Angiogenesis

Maternal and fetal angiogenesis continues throughout gestation. Angiogenesis is
the development of new blood vessels from existing vessels and is crucial for normal
growth and development (Barcroft et al., 1946; Meschia 1983; Reynolds et al., 1995).
There are two types of angiogenesis – branching and non-branching – both occur
throughout placental vascularization (Reynolds et al., 2005). Angiogenesis action is
increased during placenta vascularization. Many of the factors regulating angiogenesis
are a result of placenta vasculogenesis, including vascular endothelial growth factor
(VEGF), basic fibroblast growth factor (FGF-2), and angiopoietin protein families (ANG1 and ANG-2) (Zygmunt et al., 2003). Angiogenic proteins VEGF and FGF-2 have been
published as having activity from the placental tissues (Reynolds et al., 1988; Millaway
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et al., 1989; Zheng et al., 1998). Vascular endothelial growth factor (VEGF) is critically
important for the angiogenesis of brain ventricles, kidney glomeruli, and placental tissue
during late pregnancy (Durmont et al., 1995; Breier et al., 1997). Fibroblast growth
factor-2, produced throughout gestation, plays a dominant role in the maturity of the
uterine arterial and fetal placental arterial cells (Fokman et al., 1987; Klagsbrun et al.,
1991; Cale et al., 1997; Zheng et al., 1999).
Branching angiogenesis primarily occurs during the first two-thirds of gestation
and transitions primarily to non-branching angiogenesis during the last trimester (Geva et
al., 2002). During the first trimester, ANG-2 levels are high relative to ANG-1, which
allows fetal blood vessels to undergo changes (Geva et al., 2002). As the fetal blood
vessels change and develop, this allows the placenta to increase in size to better provide
nutrient and gas exchange. At the end of the second trimester, ANG-2 levels begin to
decrease, preventing villous destabilization and permitting the transition from primarily
branching to non-branching angiogenesis (Geva et al., 2002).

Blood circulation

The process of vasculogenesis and angiogenesis during gestation allows for
increased blood circulation to the uterus during pregnancy (Hard et al., 1982). Placental
blood flow has both chronic and acute regulators. The chronic regulators influence the
development of the placenta and vasculogenesis to control blood flow to the uterus.
Chronic regulators include reactive oxygen species, which in low levels contribute to
regulation of vascular smooth muscle and endothelial cell function in blood vessels.
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However, in instances of fetal growth restriction or preeclampsia, these reactive oxygen
species are upregulated and can lead to impaired vascular function (Tagaki et al., 1994).
Acute regulators concentrate on the diameter of the blood vessels nearest to the placenta.
Nitric oxide (NO) is an acute regulator, is activated by guanylate cyclase (cGMP), and is
a vasodilator, which results in blood vessel relaxation. Exogenous NO antagonist leads to
intrauterine growth restriction (IUGR) and preeclampsia in pregnant rats (Maul et al.,
2003). Its vasodilation action is stimulated by FGF-2 and VEGF, though NO also
regulates FGF-2 and VEGF in turn through intracrine action (Rosenfeld et al., 1996;
Babaei et al., 1998; Hood et al., 1998; Sasaki et al., 1998; Vagnoni et al., 1998; Benoit et
al., 1999; Frank et al., 1999; Zheng et al., 1999).
Maternal obesity or under nutrition can have a profound effect on both chronic
and acute regulators influencing placental blood circulation (Bird et al., 2003). The amino
acid arginine is a necessary component in NO synthesis as well as polyamines synthesis.
As previously mentioned, NO is a vasodilator directly involved in regulating blood flow
to the placenta. Arginine is one of the ten essential amino acids (i.e., required in animal’s
diet and cannot be derived from other amino acids) and therefore a suboptimal diet may
cause an arginine deficiency. This deficiency would decrease the amount of NO available
to regulate placental blood flow, subsequently decreasing polyamine synthesis (Flynn et
al., 2002). Polyamines regulate fetal DNA and protein synthesis, both of which are
required for cell differentiation and proliferation. Polyamine reduction also detrimentally
affects placental growth as well as fetal growth (Ishida et al., 2002). Citrulline (an
arginine precursor) concentration in ovine allantoic fluid increases by 34 fold between
day 30 and day 60 of gestation while glutamine (citrulline precursor) concentration
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increases by 18 fold during the same interval (Kwon et al., 2003b). The nitrogen in these
compounds makes up 60% of the total nitrogen amino acid content in ovine allantoic
fluid (Kwon et al., 2003b). When ovine placental growth is rapidly developing (Bell et
al., 2002), high rates of arginine precursors are correlated with a high level of NO and
polyamines (Kwon et al., 2003a; Kwon et al., 2004b; Wu et al., 2004). This association
suggests that arginine-dependent metabolic pathways in the conceptus are fundamental
for development (Flynn et al., 2002). Maternal under nutrition of ewes during day 28-78
of gestation led to a decrease in concentrations of arginine, citrulline, and polyamines by
nearly one-third by day 78 (Kwon et al., 2004a). These decreases would impair NO
synthesis, leading to reduced blood flow between maternal and fetal fluids. Thus,
maternal under nutrition impairs NO vasodilation and increases fetal arterial pressure in
the ovine (Ozaki et al., 2000).
On the opposite end of the spectrum, over-nutrition can also negatively affect NO
synthesis and therefore placental blood flow. In obese animals, high levels of low-density
lipoproteins or hypercholesterolemia (increased cholesterol blood levels) impairs NO
synthesis through one of several mechanisms: reduced availability of 6R)-5,6,7,8tetrahydrobiopterin (BH4 ), a co-factor for nitric oxide synthase [NOS], the enzyme
required to convert arginine to NO), a reduced expression of NOS, or the inactivation of
NOS (Maxwell et al., 1998). Ma et al. (2010) showed that from d 75 to d 135 of gestation
there was an approximately 44.9% increase in cotyledonary arteriole diameter in control
(100% NRC) sheep versus obese (150% NRC) sheep, equating to a 440% increase in
blood flow to the fetus. At d 75 of gestation, obese fetuses had an increased cotyledonary
arteriole diameter of about 35.5%, equating to a 337% increase in blood flow to the fetus
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(Ma et al., 2010). Cotyledonary arterioles develop primarily from branching angiogenesis
(Stegeman 1974) and Ma et al. (2010) observed that at d 75 of gestation, obese ewes had
decreased expression of hypoxia induced factor 1α (HIF-1α), a compound known to
stimulate angiogenesis (Shih et al., 1999; Simon et al., 2008). Likewise, there was an
observable decrease in VEGF, ANG-1, and ANG-2 in obese ewes, suggesting that there
is a fetal:maternal signal suppressing cotyledonary angiogenic factors when confronted
with maternal over nutrition (Ma et al., 2010) in order to prevent fetal overgrowth, which
would occur because of the increased amount of blood flow, and therefore nutrients,
available to the fetuses of obese ewes (Ma et al., 2010).

Placental role in fetal development

The placenta supports fetal development through metabolic and endocrine
functions. Placental lactogen (PL) is a protein hormone that stimulates partitioning of
maternal nutrition to the growing fetus (Handwerger et al., 1976). Placental lactogens are
involved in fetal growth, as deletions in the human growth hormone and placental
lactogen gene cluster has resulted in severe fetal growth retardation (Rygaard et al.,
1998). Hormones such as progesterone and estrogen also have a role in placenta
development. Estrogen produced by the placenta is metabolized into estrone sulphate
(ES) by the cotyledons (Sullivan et al., 2009). Estrone sulphate is an indicator of
placental function. Nutrition has been shown to affect placental growth, increasing ES
and bPL during late gestation in thin cows (Rasby et al., 1990) and increasing
progesterone in heifers fed to sustain a positive energy balance (Villa-Godoy et al.,
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1990). With these relationships in mind, a correlation between ES, bPL, bPAG, and
progesterone and leptin/insulin-like growth factor (IGF), as leptin (Wathes et al., 1998)
and IGF (Gad et al., 2000) are nutritionally sensitive hormones, as their concentrations
can be influenced by diet. The placental trophoblasts also produce leptin, which is then
secreted into the maternal and fetal circulation. There are several pathological conditions
that could lead to an increased leptin production, including preeclampsia and diabetes. In
preeclamptic pregnancies, this increase in leptin often stems from placental insufficiency
(Lepercq et al., 2003). Women suffering from diabetes during pregnancy may also
experience an increase in leptin concentrations, which has a positive correlation with fetal
growth (Manderson et al., 2003). Preeclampsia and diabetes are both associated with fetal
hypoxia (Hytinantti et al., 2000a; Hytinantti et al., 2000b) and low oxygen levels may
cause an increase of leptin production (Lolmede et al., 2003).

Oxygenation

Oxygen transport keeps pace with fetal growth throughout gestation (Meschia
1983; Reynolds et al., 1986; Reynolds et al., 1987). Oxygen exchange across the placenta
not only depends on blood flow to the uterus, but also gas permeability, hemoglobin (Hg)
content, pressure, and placental permeability. Oxygen diffuses through blood vessels
from the maternal tissues to the fetal tissues (Faber et al., 1966).

Maternal Nutrition
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Maternal nutrition is arguably the most significant factor in developmental
programming. The fetus is highly sensitive to maternal nutrition throughout the entire
gestation, despite the fact that fetal nutrient requirements are inconsequential during the
earliest stages of gestation (Ferrell et al., 1976). Decreased maternal nutrition can limit
fetal growth if inflected at any point in gestation. The most critical window for fetal
hypertrophy (increase in cell size) is at the end of gestation, while the most critical
window for fetal hyperplasia (cell division) and fetal development is during early
gestation (Ferrell et al., 1976).
In work done by Olausson et al. (2003), maternal nutrient restriction decreased
maternal IGF-II while IGF-1 remained unaffected. Protein restriction (60% of control
diet) in heifers during the first trimester had no effect on fetal birth weight or cotyledon
number, but increased dry cotyledon weight, suggesting compensatory gain of the
placenta after the protein restriction had ended (Perry et al., 1999). If this is true, it could
follow that protein restriction in early gestation could lead to a larger overall placenta
because of increased microvilli development, increasing nutrient exchange between the
mother and fetus and increased birth weights, though this was not observed because of
the small number of animals available (Perry et al., 1999).
In a global restriction model, dams were subjected to a nutrient restricted diet that
was also unbalanced in terms of protein (86.7% metabolizable protein) and energy
(68.1% NEm). Early gestation animals were fed either a restricted or control diet d 30-125
of gestation before harvesting. Late gestation animals in a second group were fed either a
restricted or control diet d 30-125 of gestation and d 125-245 control animals received the
same control diet while restricted animals received a dietary supplement in attempts for
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restricted animals to match BCS of control cows before harvesting at d 245. It was shown
that with global nutrient restriction during early gestation in cattle (d 30-d 125), some
fetuses had intrauterine growth restriction (IUGR) while others did not (Long et al.,
2009). The IUGR fetuses did have the expected asynchronous organ development along
with restricted growth (Schoknect et al., 1994; McMillen et al., 2001; Vonnahme et al.,
2003; Platz et al., 2008). It was reasoned that the nutrient restricted animals did not all
exhibit IUGR because the diet lacked severity and other factors (such as animal age)
played a larger role in IUGR in this particular instance (Long et al., 2009). Further, NR
animals exhibiting IUGR showed decreased cotyledonary tissue at d 125 as well as a
decrease in total placentome area when compared with NR non-IUGR and control cows
at d 125, which could account for the decrease in fetal growth in NR-IUGR cows (Long
et al., 2009). Cotyledonary tissue was also decreased in NR cattle at d 245, but
realimentation from d 125-245 allowed overall placentome size and caruncular
vasculature to increase, therefore increasing maternal blood flow and nutrient transport,
allowing the fetus to realize its full growth potential (Long et al., 2009).

Nutrient Transport (Amino Acids, Glucose, Fatty Acids)

Post embryo adhesion, the most crucial role of the placenta is nutrient transport.
Nutrients are transported via either facilitated diffusion or active transport (Hay 1994;
Reik et al., 2003). There is mounting evidence that increased levels of growth hormone
(GH) can increase the rate of facilitated diffusion (Bauer et al., 1998). Maternal IGF-1
treatments have been shown to increase transcription of facilitated glucose transporters,
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specifically Glucose Transporter 1 (GLUT1) and Glucose Transporter 3 (GLUT3) (Bauer
et al., 1998). In the mouse model, mice fed a high fat diet (32% energy from fat)
increased glucose and amino acid placental transport. Expression of GLUT1 increased by
5 fold and sodium coupled neutral amino acid transport (SNAT2) increased by 9 fold
while GLUT3 and SNAT4 were both unchanged in expression as compared with the
control (11% energy from fat). In nutrient restricted mice, there is a decrease in GLUT3
transporters and leucine amino acid transporter (LAT) family member 2. However, there
was no change in expression of GLUT1, LAT1, SNAT, or SNAT2 transporters. This
suggests that GLUT3 and LAT2 transporters are decreased so that GLUT1, LAT, SNAT
and SNAT2 can attempt to compensate for the lack of nutrients (Ganguly et al., 2012).
In the sheep model, obese (150% NRC) ewes showed an increased expression of
Fatty Acid Transporter (FATP) 1 and FATP 4 during midgestation, the two transporters
primarily responsible for placental fatty acid uptake. Additionally, it was discovered that
fetuses from obese dams had an increased fatty acid concentration in their circulation
(Zhu et al., 2010b). These findings suggest that maternal obesity prior to and during
pregnancy increase nutrient transport from dam to fetus, leading to fetal overgrowth and
possible metabolic issues (such as metabolic syndrome) in the postnatal animal (Jones et
al., 2009). Metabolic syndrome includes multiple metabolic issues including obesity,
hypertension, dyslipidemia, and glucose intolerance. Typically metabolic syndrome
affects offspring from obese mothers who also suffer from diabetes during pregnancy
(Boney et al., 2005).
Transport of materials across the placenta depends on the outer trophoblast
surface and the inner vascular endothelial surface (Leiser et al., 1997). Amino acids are
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important in fetal development because they are required in the production of fetal
neurotransmitters, proteins, and nucleotides (Avagliano et al., 2012). Previously
mentioned, the terminal villi are responsible for nutrient/gas exchange in the placenta and
this includes amino acids. The amino acids must cross both the microvillus plasma
membrane and the basal membrane before reaching the fetus. Amino acids have an active
transport across the placenta, from maternal to fetal circulation (Phillips et al., 1978). The
placenta contains a higher concentration of amino acids than either the maternal or fetal
environment. The placenta not only provides transport of amino acids from maternal to
fetus, but also utilizes the amino acids. This utilization helps determine the flow of amino
acids into the fetus (Montgomery et al., 1982). In a 2007 study, Baggs ewes were
assigned to control and nutrient restricted (50% restriction NRC requirements) dietary
treatments and at day 78 of pregnancy, the ewes were euthanized and amino acid
concentrations of maternal and fetal plasma were tested. The nutrient restricted Baggs
ewes showed a decrease in concentrations of 9 amino acids as compared with control
ewes. However, the fetal amino acid concentrations showed no difference between the
two groups. This suggests that through indirect selection, it is possible for the dam to
overcome nutrient restriction by increased placental efficiency (Jobgen et al., 2007). Two
major classes of amino acid transporters have been identified Na+ dependent transporters
and Na+ independent transporters. These transporters are located at both the microvillus
plasma membrane and the basal membrane. The microvillus plasma membrane has Na+
dependent transporters, because energy is required to work against the concentration
gradient. The basal membrane is less studied, but it has been suggested that amino acids
pass through via facilitated diffusion (Desforges et al., 2010). Glucose is transported
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through GLUT1 and GLUT3 transporters. The GLUT1 transporter is responsible for
transport of glucose from the maternal tissues to the placenta and the GLUT2 transporter
then moves glucose from the placenta into the fetal tissues (Bauer et al., 1998). Maternal
IGF-1 increases the transport of both glucose and amino acids (Bauer et al., 1998).
Fatty acids in the fetus are precursors to cell membranes and other crucial
structures, as well as energy and cellular metabolism. The fetal brain and retinas have
heavy concentrations of arachidonic acid and docosahexaenoic acid, both long
conjugated polyunsaturated fatty acids (LCPUFA), indicating a high need for fatty acids
during early gestation. Linoleic and linolenic fatty acids in the maternal diet are
metabolized into LCPUFAs, indicating maternal metabolism of linoleic and linolenic
acid crucial for fetal development. Fatty acid transport from the maternal circulation to
the placenta has limited data, but there have been some studies done. Competition studies
with fatty acids led to the conclusion that binding sites on the placenta have the highest
affinity for LCPUFAs (Dutta-Roy 2000). However, when trans fatty acids were
introduced into the competition, trans fatty acids outstripped the affinity of LCPUFAs
(Campbell et al., 1996). Trans fatty acids may have detrimental effects on the fetus by
blocking the positive effects of LCPUFAs. Analysis of fatty acid binding protein (FABP)
through polyacrylamide gel radio binding assay and Western blot analysis led to the
conclusion that FABP (Campbell et al., 1994) is located on the microvillus membrane on
the maternal side in the human placenta, suggesting that fatty acids flow only from the
maternal to the fetus, with no back flow (Dutta-Roy 1997). Some data suggests that
linoleic acid travels to the fetal tissues from the maternal via synchtiotrophoblast
membranes (Simneau et al., 1994).
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Maternal obesity increases the expression of fatty acid transporters in the
placenta, increasing the rate at which the fetus receives fatty acids (Zhu et al., 2010b).
The increase of fatty acids in fetal circulation leads to inflammation in fetal tissues (Tong
et al., 2009; Yan et al., 2010). Dube et al. (2012) reported that maternal obesity in
humans leads to altered expression of fatty acid transport proteins on both sides of the
synctiotrophoblast: SLC27A4 and CD36. A study by Larque et al. (2006) suggests that
SLC27A4 in the placenta is more involved with fatty acid esterification rather than
transport and decreased expression would alter the esterification of fatty acids rather than
the uptake. Increased expression of CD36 is likely correlated to the high levels of T3
(Feng et al., 2000) in obese women and increases fatty acid uptake and metabolism (Dube
et al., 2012).

Normal and abnormal hormones

Glucocorticoids

Smith et al. (1973) analyzed maternal bovine serum glucocorticoid concentrations
d 26 prior to parturition until d 9 post parturition. They concluded that glucocorticoid
concentration stays fairly constant (5.1 ng/mL) until approximately 12 h prior to
parturition, when glucocorticoid concentration nearly doubles (10.3 ng/mL). At
parturition, glucocorticoid concentrations increased ~50% to 16.7 ng/mL. Post
parturition, glucocorticoid concentration returned to the levels observes in the days
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leading up to parturition (5.1 ng/mL). These findings suggest that glucocorticoids play a
major role in initiation of parturition.
Glucocorticoids are generally found in low concentrations in fetal circulation.
Glucocorticoids move to the fetal from the maternal environment down a concentration
gradient and are regulated by placental 11β-Hydroxysteroid dehydrogenase (11βHSDS),
an enzyme that converts maternal glucocorticoids and cortisol into metabolites (Fowden
et al., 2004). This enzyme is crucially important to limiting fetal exposure to active
maternal glucocorticoids (Fowden et al., 2004). While fetal glucocorticoid levels are low,
it appears that they have a limited effect on tissue growth. However, when
glucocorticoids are exogenously administered or 11βHSDS activity declines (leading to
an increase in endogenous glucocorticoids), fetal growth actually declines. However, this
is limited to mechanical growth, because the glucocorticoids cause the maturation of
tissues and activation of biochemical processes that are not required in utero (Fowden et
al., 2004). The rise in glucocorticoids suggests that stress on the dam causes fetus
compensation by reducing mechanical growth and increasing tissue maturation to prepare
for post natal life earlier than would otherwise be normal (Fowden et al., 2004). Synthetic
glucocorticoids are used as therapy to increase survival of premature neonates by
accelerating lung maturation if administered at the appropriate time during gestation
(Liggins 1969; Liggins et al., 1972). Some synthetic glucocorticoids such as
dexamethasone or betamethasone are unaffected by 11βHSDS and cross the placenta
easily without any structural changes. Other substrates such as prenesilone are rapidly
inactivated by 11βHSDS (Brown et al., 1996). The type of exogenous glucocorticoid
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administered during pregnancy is important dependent on its intended effect (maternal
versus fetal) and ability to cross into the placenta.
Glucocorticoids accelerate fetal lung development in sheep (Liggins 1969).
Furthermore, when pregnant ewes were administered exogenous synthetic
glucocorticoids, lambs were more likely to survive premature birth (Liggins 1969).
Despite the increased lung maturation, there is evidence to suggest that synthetic
glucocorticoids may have deleterious long-term effects on endocrine, renal, and
metabolic function (Long et al, 2013b).

IGFs

During gestation, IGF-1 concentrations in the maternal environment are greater
than the concentration of IGF-I in the fetus. IGF-II is more prevalent in prenatal life
(Godfredson et al., 1991). Other key hormones associated with fetal development
regulate IGF hormones. Human placental lactogen (hPL) shares similar biological traits
to growth hormone and it has been suggested that placental lactogen is the fetal
equivalent to growth hormone (Underwood et al., 1984), making placental lactogen the
primary stimulus for IGFs during embryonic development). Efstratiadis (1998) reported
that blocking of IGF genes or IGF-1 receptor led to a severe growth retardation, while
overexpression led to overgrowth; furthermore, fetal exposure to differing levels of IGF
showed abnormal development of tissues including bone, skin, respiratory, and muscles.
Fetal IGF-I has little effect on body weight, but alters growth of individual tissues
(Fowden et al., 2004). Insulin-like growth factors affect fetal growth both through
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metabolic and non-metabolic action, working in the cell cycle to prevent apoptosis and
increasing DNA and protein synthesis (Hill et al., 1998). Insulin-like growth factor-1 is
involved in tissue accretion and is more sensitive to nutrition deficiencies, while fetal
IGF-II provides a general cell growth stimulus (Fowden et al., 2004). It has been shown
that IGF-I infusions causes an increase in fetal blood glucose concentrations but does not
change glucose uptake in either the maternal or fetal environment. Furthermore, maternal
plasma insulin levels and both maternal and fetal blood amino nitrogen concentrations
fell. There were no observed changes in levels of fetal protein oxidation, feto-placental
oxygenation, placental blood flow, or placental transfer by either simple or facilitated
diffusion (Liu et al., 2013).

Leptin

Adipocytes and the placenta produce leptin and its concentration has a positive
correlation with fetal growth (Cinaz et al., 1999). In postnatal life, insulin, GH, and IGF
regulate leptin and there is a possibility that this relationship may also occur in utero.
Leptin is positively correlated with birth weight (Marchini, et al., 1998). The timing of
the initial postnatal leptin peak is crucial to setting the appetite regulation centers (Long
et al., 2011). The lack of a leptin peak, as seen in offspring from obese dams can lead to
an imperfect set point in the appetite control center, causing the offspring to eat more and
put on more adipose tissue when exposed to increased nutrition postnatally (Long et al.,
2011).
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Epigenetics

“Epigenetics” is the term applied when there has been no change in gene
sequencing but there is an observable difference in gene expression (Wilkins 2005). DNA
methylation and chromatin organization are the two main contributors to epigenetics
(Probst et al., 2009). Changes in gene expression can alter how nutrients are transported
across cell membranes and even from the dam to the fetus during gestation.

Genes

There are more than 100 genes involved in placental development and function
(Hemberger et al., 2001; Rossant et al., 2001; Simmons et al., 2005; Watson et al., 2005).
Several gene families expressed in the ruminant placenta encode the intercellular
signaling proteins pregnancy associated glycoproteins, trophoblast Kunitz domain
proteins, and IFN-τ (Elsik et al., 2009). These proteins regulate aspects specific to
ruminants including fetal growth, maternal immune function, maternal adaptations,
endocrine function, and parturition (Larson et al., 2006; Hashizume et al., 2007).

Amino Acids and Micronutrients

During gestation, nutrient requirements of the dam greatly increase, especially
protein as the fetus is creating muscle, making the demand for amino acids much higher
than in a maintenance requirement for a postnatal animal (Langley-Evans et al., 2006).
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However, the protein profile must be well balanced in amino acids, as high circulating
levels of particular amino acids can cause toxicity (Langley-Evans et al., 2006).
DNA methylation relies on methyl group donors and cofactors, which it receives
from methionine and folate metabolism. Methionine is an amino acid and its levels in the
body are dependent on dietary intake and protein degradation (Chmurzynska 2010).
There are two main reactions that contest for methionine: protein synthesis and Sadenosylmethionine (Finkelstein 1998). S-adenosylmethionine is a coenzyme and major
methyl donor for several cellular processes, including DNA methylation (Brosnan et al.,
2006). Demethylated S-adenosylmethionine becomes S-adenosylhomocystein and high
levels can actually inhibit methylation (Mason 2003) and therefore must be eliminated for
proper flow of the methionine cycle (Finkelstein 1998). The methionine cycle is
dependent on the folate cycle. Folate from the diet is converted to methyl-THF, which is
the main form of circulating folate in humans. The methyl group from methyl-THF can
be used in the remethylation of homocysteine all the way back to methionine via
methionine synthase (Chmurzynska 2010). Methionine synthase requires the vitamin
cobalamin and enzymes within the reaction require pyridoxal phosphate, a B6 vitamin
(Brosnan et al., 2006). While dietary requirements of methionine, folate, and B6 vitamins
in the dam are very small, without them it would be impossible to successfully perform
DNA methylation in the fetus.
High levels of methionine can be toxic to the developing fetus, as the methylation
of SAH requires methyl groups from THF (derived from ingested folate). Furthermore,
homocysteine may not be eliminated because the fetus is lacking in the synthases
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responsible for homocysteine elimination. The increased methylation of homocysteine
depletes methylated folate levels, leading to a folate deficiency (Rees et al., 2006).

DNA methylation/histone modification

It is suggested that poor nutrition during gestation may detrimentally alter
postnatal function through changes in DNA methylation (Rakyan et al., 2001). In
mammals, DNA methylation occurs at the fifth position of the pyrimidine ring of
cytosine base followed by guanine, known as CpG dinucleotides (Rakyan et al., 2001).
The 5’ end and promoter regions of DNA contain CpG islands, which are clusters of nonmethylated CG rich areas (Sulewska et al., 2007). Methylation of these islands decreases
transcription (Urnov 2002). It has been suggested that methylation is reversible and that
the balance is dependent on the rate of methylation and demethylation (Delcuve et al.,
2009; Niehrs 2009). During gestation, methylation is catalyzed by DNA methyltransferse
1 (Dnmt 1) and maintained by both Dnmt 3A and Dnmt 3B (Rakyan et al., 2001). As
gestation progresses and the fetus becomes more differentiated, Dnmt 1 decreases
(Turek-Plewa et al., 2005). Mutations to any of the DNMTs led to abnormal development
or fetal mortality (Gaudet et al., 2003). In mice, a down regulation of Dnmt 1 leads to
hypomethylation of all tissues, which led to tumors in the postnatal life (Gaudet et al.,
2003). When Dnmt 3A and 3B were blocked to stem cells and the early embryo, there
was no effect on maintenance of methylation. However, Dnmt 3A blocked mice were
born normal and died 4 weeks later and Dnmt 3B blocked mice were born dead with
multiple abnormal defects (Okano et al., 1999).
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In the nucleus, DNA exists as a nucleoprotein called chromatin. Chromatin is
made up of individual nucleosomes. A nucleosome is comprised of 146 DNA base pairs
wrapped around 8 histone proteins – four different proteins in duplicate (Rakyan et al.,
2001). Any change to the histone structure affects nucleosome structure and therefore
function. Changes in nucleosome structure affect its accessibility to transcription
machinery within the cell (Munshi et al., 2009). Histones undergo reversible post
translation modification including the methylation and phosphorylation of different
amino acids. Other histone modifications also include the regulation of gene expression
by transcription activation, transcription repression, repression of specific genes,
chromatin remodeling, nucleosome loosening, and chromatin stabilization – all of which
can stimulate or repress gene expression (Munshi et al., 2009).

Gene expression

Chromosomes are comprised of two different parts: euchromatin and
heterochromatin. Euchromatin is transcriptionally active where heterochromatin is
inaccessible to DNA binding and therefore transcriptionally inactive (Grewal et al.,
2002). Large blocks of heterochromatin surround centromeres and telomeres while
smaller pieces are interspersed throughout the chromosome (Grewal et al., 2002).
Heterochromatin plays a crucial role in centromere function (Grewal et al., 2002), as well
as sister chromatin cohesion and chromosome segregation (Bernard et al., 2001; Peters et
al., 2001; Nonanka et al., 2002). Heterochromatin stabilizes DNA sequences (Grewal et
al., 1997) and controls the regulation of gene expression during development and
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differentiation through the stable inactivation of developmental regulators (Cavalli et al.,
2002). The haploid eukaryote cell DNA content is measured by its “C-value” (Thomas
1971). While initially thought to be correlated to gene number and species complexity, it
has since been agreed that there is no significant correlation between species gene
number, developmental complexity, and the C-value (Thomas 1971).

Genomic imprinting

Genomic imprinting has a significant effect on human genetic diseases (Nicholls
et al., 1989). The key mechanism of imprinting is DNA methylation (Reik et al., 1987);
methylation marks imprinted genes differently (Sapiens et al., 1987) and inheritance of
epigenetic markers leads to different gene expression (Swain et al., 1987). Imprinted
genes are important in the phenotypic effect and control fetal growth and postnatal
behavior. There have been no observable differences in protein sequences encoded by
imprinted genes, though there are functional relationships between proteins with roles in
fetal development. All imprinted genes have two general features in common: They are
rich in CpG islands and have clustered/direct repeats near or within the CpG islands
(Reik et al., 2001).
The majority of imprinted genes show different DNA methylation than parental
alleles, but differentially methylated regions have different properties. Imprinted genes
can differ in chromatin structure and histone acetylation (Ferguson-Smith et al., 1993).
Lastly, imprinted genes may have two large effects: DNA in imprinted regions replicate
asynchronously in S phase of cell cycle and have different frequencies of meiotic
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recombination found in or near imprinted clusters, though the effect on DNA methylation
is unclear (Reik et al., 2001).
In a non-human primate study, animals from dams receiving a 70% restricted diet
(MNR) showed little external phenotypic differences than animals from dams receiving
the control diet (CTR). Despite this, there were significant differences between the MNR
and CTR groups when comparing structure, gene, and protein abundance in placenta,
fetal liver and kidney (Nijland et al., 2010). This study suggest that fetal weight and the
weight of individual fetal organs is an inadequate measure of compromised fetal
development and analysis of cellular structure and function at the molecular level is
required to determine the nature and mechanisms responsible for fetal adaptations
resulting from maternal challenges during pregnancy (Nijland et al., 2010), a conclusion
previously put forth by Armitage et al. (2004) and Zambrano et al. (2005b). The fetal
renal system contains mammalian target rapamycin (mTOR), which is a sensor of
nutrient stress and has been shown to decrease in the primate fetal kidney with a 30%
nutrient restriction in the dam, suggesting the fetus has the ability to sense a decrease in
nutrients (Nijland et al., 2007). Furthermore, an increase in fetal liver glycogen occurs in
nutrient challenged dams with a 30% decrease in dam nutrition (Li et al., 2007),
suggesting that the fetus can initiate mechanisms to conserve energy by decreasing
glycolysis or increasing glucose availability through gluconeogenesis (Nijland et al.,
2010).
In the pregnant rat model, a low protein and high carbohydrate diet lead to an
increase of enzyme activity of fetal liver PEPCK (Franko et al., 2009), which indicates
that there are multiple mechanisms of activation for an increase in hepatic PEPCK other

	
  35	
  

than a direct stimulation from mature fetal systems (Kwong et al., 2007). However, the
duration and severity of the challenge may be significant, as fetal hepatic PCK1 mRNA
does not increase in sheep after d110 if challenged (Hyatt et al, 2008), though there may
be some species differences (Nijland et al., 2010).
Cortisol is accepted as a key regulator of PEPCK, mediated by glucocorticoid
response element (GRE) in the PCK1 gene promoter (Cassuto et al., 2005). In the sheep
model, intravenous cortisol in fetal sheep showed an increase in fetal liver glycogen
deposition as well as glucose-6-phosphatase and PEPCK activity (Fowden et al., 1993).
Maternally administered dexamethasone had no effect on PEPCK activity, but showed an
increase in glucose-6-phosphatase activity. The differences in fetal versus maternal
dexamethasone administration suggests that dexamethasone primarily affects
glycogenolysis in the fetal liver (Franko et al., 2007).

MicroRNA and Placental Development

MicroRNAs are small, noncoding RNAs that are 20-25 nucleotides long.
MicroRNAs regulate posttranscriptional gene expression by binding to the 3’
untranslated region of their target RNAs, generally messenger RNA (Bartel et al., 2004).
MicroRNAs (miRNA) have recently been discovered to have a significant role in
trophoblast function including regulation of maternal-fetal immunology, trophoblast
differentiation in placental development, angiogenesis, vasculogenesis, oxygen sensing,
and links between miRNA and imprinted genes (Varrault et al, 2006; Doridot et al., 2013;
Renfree et al., 2013). Angiogenesis, as previously discussed, is key to early placentation
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and involves the remodeling of uterine arteries and blood vessels. Impaired remodeling of
the uterine arteries leads to reduced blood flow to the placenta and subsequent decreased
oxygen delivery as well as increased cell injury, inflammation, and debris ending up in
maternal circulation (Doridot et al., 2013). The relationship of miRNAs and angiogenesis
is still unclear, but a recently published study has found an increased expression of miR17 miRNAs in preeclampsia (PE) versus normotensive human placentas (Wang et al.,
2012). Two ephrin receptors involved in angiogenesis, B4 (EPHB4) and B2 (EPHB2)
(Wang et al., 1998), have been identified as potential targets of the miR-17 family (Wang
et al., 2012), as the coupling of EPHB4/EPHB2 drives extravillous trophoblasts (EVTs)
away from the placenta and towards uterine arterioles to facilitate branching (Red-Horse
et al., 2005).
The Notch pathway has been previously proven to play a role in vascular
patterning and specification of arterial identity (Roca et al., 2007; Swift et al., 2009) and
it is now thought to have a part in artery remodeling (Hunkapiller et al., 2011). The
components of this pathway include four transmembrane receptors (Notch1-4) and five
ligands (Delta1/3/4 and Jagged1/2) (Hunkapiller et al., 2011). MiRNAs are involved in
Notch signaling, including miR-210, which is the most up-regulated miRNA in PE
(Pineles et al., 2007). While the underlying mechanisms for preeclampsia are largely
unknown, placenta and trophoblast dysfunction are requisites for development of PE
(Goldman-Wohl et al., 2002; Rampersad et al., 2007). Increased expression of miRNA in
the preclampsic placenta suggests that miR-210 is involved in trophoblast migration and
invasion (Zhang et al, 2012).
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Increased expression of miR-210 leads to an increased expression of Notch1,
which induces migration and tube formation in Matrigel (gelatinous protein mixture
secreted by mouse sarcoma cells) (Lou et al., 2012). Vascular smooth muscle cells have
an increased expression of contractile proteins through Notch signaling and Jagged1
pathway, facilitated through the transcription of miR-143/145 (Boucher et al., 2011).
Several miRNAs, including miR-9, miR-21, miR-27, miR-124, miR-130, miR-148, and
miR-181 are predicted to target the Notch pathway and are thought to be involved in
vascular development and extracellular signaling, though the full interactions are not
completely understood (Anand 2013).
Trophoblast cells express human leukocyte antigen (HLA)-G (Hunt et al., 2006)
and HLA-C (Hiby et al., 2004). Human leukocyte antigen G is considered a general
immune tolerance molecule (Wiendl et al., 2005; Carosella, 2011; Gonzalez et al., 2012).
It is expressed by extravillous trophoblasts and its expression is regulated by mir-152
(Tan et al., 2007) and mir-148 (Manaster et al., 2012). Human leukocyte antigen C
regulation has not been fully elucidated, but is still strongly expressed in cells from
trophoblast origin (Manaester et al., 2012).

Postnatal disease susceptibility

The phenotype of an animal results from the interaction of genetics and
environment. Two genetically identical animals may exhibit a different phenotype if
raised in a different environment and two animals with different genetics in the same
environment will likewise develop differently and may exhibit a different level of
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production. The environment during prenatal and early postnatal life has the greatest
affect on the adult animal (Yajnik 2004). These environmental factors can increase the
risk of adult chronic diseases (St Clair et al., 2005), including mental diseases such as
schizophrenia and an altered ability to respond to stress (van Os et al., 1998). Alterations
to epigenetic marks play a central role in determining the expression of genes stored in
the animal’s genome (Jirtle et al., 2007).
Changes in epigenetic status can be because of either molecular modification of
DNA or the chromatin via DNA methylation (Li 2002; Klose et al., 2006; Talbert et al.,
2006; Richards 2006) or can be a change of non-coding RNAs, such as micro RNAs
(Thorvaldsen et al., 2006). Changes can be inherited mitotically through effects of
nutritional supplements (Wolff et al., 1998), chemicals (Li et al., 2003), behavior cues
(Weaver et al., 2004), reproduction factors (Niemitz et al., 2004), and radiation
(Koturbash et al., 2006). Changes can also have a long-term effect on multiple
generations (Anyway et al., 2006).
Environmental changes can be nutritional, chemical, or physical factors. There are
3 genomic targets for environmental changes: promoter regions of housekeeping genes,
which are unmethylated; transposable elements that lie adjacent to genes with metastable
epialleles, which are methylated; regulatory elements of imprinted genes, which are
differentiated methylated. Methylation status determines level of gene expression and a
change in level of methylation can alter animal function and survivability (Jirtle et al.,
2007).

Postnatal
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Average Daily Gain (ADG)

In production systems, ADG is a rate of weight gain per day over a specific period
of time. Factors decreasing ADG can be detrimental to a production system. In a porcine
study, no alterations on maternal diet or diet in piglets post weaning through finishing,
led to a decreased ADG in piglets with a lower birth weight (Gondret et al., 2005),
suggesting that lighter animals at birth are poorly prepared for adequate levels of ADG on
a normal plane of nutrition. A nutritional study using cattle during early gestation showed
that limited nutrition or moderate nutrition during the first third of gestation had no effect
on calf birth weight or subsequent ADG during any of the production phases (weaning,
finishing, etc.) (Long et al., 2010), suggesting that postnatal growth of bovine fetuses are
not particularly sensitive to early gestation nutrient restriction.
In calves from dams who were subjected to nutrient restriction during the last half
and last third of gestation, calf birth weights were lower and this caused a significant
decrease in ADG at every production stage (weaning, back grounding, finishing) up to 30
months of age, compared with non-restricted animals (Greenwood et al., 2005). Heifers
showed a lower calf birth weight than cows if subjected to nutrient restriction during midand late gestation, but cows and heifers showed similar decreases in calf birth weight
when nutrient restriction was limited to the last one third of gestation (Greenwood et al.,
2005).

Insulin Resistance
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Undernutrition in ewes (fed 1-2 % of body weight versus 3-4% body weight for
control ewes) from 61 days before breeding to 30 days post conception showed an
increased fetal insulin response to glucose during late gestation (Oliver et al., 2001). In
contrast, prolonged undernutrition during gestation showed decreased fetal insulin
response to glucose in sheep (Limesand et al., 2003). Another study showed that
undernutrition during late gestation resulted in glucose intolerance in yearling lambs
(Gardner et al., 2005), which was associated with a decreased expression of GLUT4
receptors in adipose, but showed no changes in expression in muscle tissue (Poore et al.,
2002). Ford et al. (2007) subjected 2 groups of wether lambs to two glucose tolerance
tests. Control lambs were from ewes fed a diet at 100% of NRC requirements throughout
gestation. Nutrient restricted lambs were from ewes fed the same control diet, but at 50%
of NRC requirements d 28 – 79 of gestation, after which they were fed the same ration as
the control group. The glucose tolerance tests were conducted at d 63 and d 250 of age as
to occur pre- and post-weaning. In both glucose tolerance tests, both groups showed a
similar baseline. Prior to weaning, nutrient restricted lambs had increased insulin
concentrations as compared with control lambs. Post-weaning, nutrient restriction
wethers had decreased insulin concentrations as compared with control lambs. This
dynamic change in insulin concentration in nutrient restriction lambs is indicative of
pancreatic β-cell dysfunction, leading to an overproduction during early life and rapidly
degrading as the animal ages (Simmons et al., 2001). This evidence suggests that
undernutrition during any point in gestation has a long-term effect on insulin and glucose
resistance in the postnatal animal.
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Maturation of the hypothalamic pituitary axis and its effects on cognition

The hypothalamic pituitary adrenal axis (HPAA) is responsible for final fetal
maturation during late gestation through production of glucocorticoids (Liggins 1994).
The glucocorticoids enter fetal circulation and act as a maturation catalyst for organs and
metabolic pathways to prepare the fetus for postnatal life (Liggins 1968). The surge of
cortisol levels is also a maternal signal to begin labor (Liggins et al., 1973). Exposure to
maternal glucocorticoids or synthetic glucocorticoids during critical windows is a
mechanism in fetal programming and can lead to altered development of the HPAA and
hypertension (Benediktsson et al., 1993; Welberg et al., 2001). Exposure to maternal
glucocorticoids most often stems from maternal undernutrition. Lack of nutrients puts
stress on the animal, causing her to produce higher levels of cortisol hormones,
increasing fetal exposure (Edwards et al., 2001).
Insults on the HPAA are permanent as exposure to glucocorticoids during critical
windows alters the development and therefore function during postnatal life. High
cortisol levels are associated with atherosclerosis, immunosuppression, depression,
cognitive impairment, and increased cholesterol levels (Sapolsky 2000). Depressed
cognitive impairment is most likely because the insults on the HPAA have likewise
compromised the development of the hippocampus. This upset on the hippocampus is not
noticed until later in life, when cognitive ability begins to decline before expected in the
normal aging process. The hippocampus is most often associated with memory and with
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the decreased operating capacity of the hippocampus comes a loss of memory and
therefore cognitive function (Lupien et al., 2001).

Increase adiposity

It has been suggested that offspring from overweight mothers are more prone to
becoming overweight (Plagemann et al., 1997; Silverman et al., 1998). Studies in the
sheep model have shown that this is most likely because of a gestational programming
affecting the appetite regulation center in the brain. Pregnant sheep were fed either a
control diet or a well-fed diet (~100%, ~160% of metabolizable energy requirements,
respectively) (Muhlhausler et al., 2006). Thirty days post lambing, lambs were sacrificed
and fat samples were taken. Lambs from well-fed dams had an increased amount of
subcutaneous fat when compared with control lambs. Furthermore, expression of appetite
regulating genes in lambs from well-fed dams was altered to allow for increased
adiposity (Muhlhausler et al., 2006). Further studies with obese ewes showed lambs with
an increased fetal adiposity without a change in fetal body weight, suggesting that fetal
adipose mass is independent of body weight (Ford et al., 2009). Later in life, this increase
in neonatal adiposity can lead to early childhood obesity and even obesity into adult life
(Catalano et al., 2003).

Decrease skeletal development
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Skeletal muscle development and bone development often reflect each other.
Animals with a higher amount of muscle are more likely to have a stronger skeleton and
vice versa (Frost 2001). Skeletal muscle development begins before bone development
and it has been suggested that proper skeletal muscle development is crucial for adequate
bone development, as heavier muscles would initiate an increase in bone strength
(Schoenau et al., 2005; Pludowski et al., 2006). A study in maintenance fed (fed 100 %
maintenance requirements based on NRC) and well-fed sheep (given ad libitum access to
pasture) showed that lambs from well-fed sheep had stronger bones (as measured by bone
mineral content) than lambs from maintenance diet dams (Firth et al., 2008). Maternal
under nutrition leads to a decrease in hyperplasia of muscle fibers (Dwyer et al., 1994)
and it could therefore be argued that a decrease in skeletal muscle development would
subsequently lead to a decrease in bone development. Furthermore, skeletal muscle
growth is crucial in utero, because muscle fiber numbers do not increase after birth.
During gestation, skeletal muscle has low priority for nutrition partitioning compared
with heart and brain development, making it particularly vulnerable to nutrient insults
(Bauman et al., 1982; Close et al., 1990). In nutrient restricted ewes during early to mid
gestation (Zhu et al., 2006), skeletal muscle was decreased in developing lambs. In
nutrient restricted (50 %) cattle during early gestation (d 30 – d 125), fetuses were found
to have increased levels of calpastatin (Du et al., 2004). Calpastatin inhibits calpains,
which are proteases responsible for muscle degradation (Barnoy et al., 2000). The
increased levels of calpastatin in nutrient restricted fetuses suggests that nutrition levels
play a role in fetal muscle maintenance (Du et al., 2004). In nutrient restricted (60 %)
cattle during early gestation (d 30 – d 85) showed decreased myofiber diameter
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(Gonzalez et al., 2013). As skeletal muscle is the primary site for insulin resistance in
obese and type 2 diabetes patients (Kemp et al., 2003; Lowell et al., 2005), it is suggested
that the decrease in skeletal muscle predisposes the animal to obesity and glucose/insulin
dysregulation later in life (Stannard et al., 2004; Zambrano et al., 2005a). Further, while
nutrient restricted ewes had significantly increased muscle fiber diameter, the distribution
of myosin was altered from that of the control fed ewes. Nutrient restricted ewes had a
significantly increased distribution of myosin IIb fibers, which are the least insulin
sensitive, and significantly decreased myosin Ia type fibers, which are the most insulin
sensitive. The altered muscle fiber distribution may contribute to glucose intolerance in
the postnatal lambs (Zhu et al., 2006).

Thermogenesis

IUGR can affect the development of skeletal muscles and adiposity, particular
visceral adipose tissue (Bagley et al., 2013), both of which are key factors in
thermogenesis. A decrease in skeletal muscle decreases the animal’s ability for
respiration, posture, and thermogenesis (Rossdale et al., 2002).
Furthermore, maternal under nutrition decreases the adipose tissue mass in
newborn animals. As most newborn animals receive 50% of their heat production
through thermogenesis in brown fat, the decrease in adipose tissue mass could increase
mortality of newborn animals (Satterfield et al., 2013). Restriction of prepartum protein
(Carstens et al., 1987) or energy (Ridder et al., 1991) of heifers decreased the
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thermoneutral metabolism capacity in newborn calves. Carstens et al. (1987) showed that
the decrease in metabolic capacity was independent of birth weight.

Glucose and insulin levels

IUGR can lead to adult diseases, including non-insulin dependent diabetes
mellitus (NIDDM) as a result of increased insulin resistance, decreased insulin secretion,
or a combination of both. Maternal under nutrition often leads to an increased resistance
to both glucose and insulin. Studies in prepubertal children have shown that plasma
glucose levels are inversely related to birth weight. These levels are indicative of an
increased chance of NIDDM later in life (Veening et al., 2002).

Transgenerational effects

In a multi generation study, it was shown that an F2 generation can be affected by
the diet fed to the F0 generation during gestation without changing the diet of the F1
generation. In a study by Pineherio et al. (2008), virgin female rats (F0) were blocked
into one of 4 treatments: CC (control diet during gestation and lactation), CR (control diet
during gestation, restricted during lactation), RC (restricted diet during gestation, control
diet during lactation), and RR (restricted diet during gestation and lactation). The
restricted diet consisted of a decreased protein intake while remaining isoenergetic for all
groups. Once weaned, the F1 generation was kept on a control diet throughout gestation
and lactation.
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In the F1 generation, there were no significant differences between the treatment
groups for litter size, pup mortality, or gender. Body mass and naso-anal length were
decreased for offspring of both RC and RR rats. RC1 rats (offspring of RC rats; F1
generation2) had a “catch up” growth when compared with CC1, while both CR1 and
RR1 had decreased growth. Male RC1 rats had increased fasting glucose and showed
evidence of insulin resistance, though there were no significant differences in circulating
plasma insulin. Male RC1 rats also had increased circulating leptin versus CC1, CR1, and
RR1 treatment groups.
Data collected on the F2 generation was consistent in showing that F0 diet had an
impact on hormone levels, though all F1 rats were fed a control diet throughout gestation
and lactation. RC2 (offspring of RC1 rats; F2 generation) rats were heavier and had a
longer naso-anal length versus CC2 offspring, but this change was gone at weaning. CR2,
RC2, and RR2 offspring were all heavier than their F1 counterparts. Overall, there was
no significant change in growth rate between the F2 offspring. Fasting glucose was
increased for groups CR2, RC2, and RR2 when compared with CC2 and plasma glucose
was increased in the CR2 group versus RC2 and RR2 and treatment groups CR2 and RR2
had increased glucose levels when compared with their F1 counterparts. Fasting insulin
was increased in CR2 and RC2 versus CC2 and plasma insulin was increased for CR2
and RC2 versus RR2. Plasma insulin was also significant increased in CR2 and RC2
when compared with their F1 counterparts. CR2 and RC2 male offspring showed an
increased insulin resistance when compared with RR2 and CC2, and insulin resistance
was increased in the F2 generations versus the F1 generation. Lastly, plasma leptin was
increased in CR2 versus other F2 offspring as well as its F1 counterpart. The data
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collected from this study shows that a restricted maternal diet can have effects far beyond
their offspring.
In the guinea pig, maternal under-nutrition modifies the HPA (hypothalamic
pituitary adrenal) and cardiovascular function in the F2 generation (Dobbing et al., 1970;
Dobbing et al., 1979; Owen et al., 2003; Owen et al., 2005). The F0 generation was fed
70% of the control diet during either the first half or second half of gestation. The F1
generation was fed ad libitum during production of the F2 generation. Birth weight and
growth were most affected in restricted animals versus control, but showed greater
changes in the F2 generation than the F1 generation. Both generations had increased
cortisol levels and changes in HPA response from the control group, though the changes
were more marked from late gestation restricted F0 dams. F1 offspring from early
gestation restriction had increased blood pressure and left ventricular wall thickness from
the control group; effects that were also passed to the F2 generation (Bertram et al.,
2008).
In multigenerational sheep studies, it was shown that glucocorticoid treatment
(dexamethasone) in solely the F0 generation during pregnancy led to growth restriction in
subsequent F1 and F2 generations (Long et al., 2013b). While glucocorticoids are
successful in preventing preterm delivery in humans, it is important to consider potential
consequences not only to the F1 generation but also to the generations following (Long et
al., 2013b). Also, synthetic glucocorticoid treatment to the F0 generation during
pregnancy led to postnatal changes in the F2 generation including a decreased postnatal
leptin peak, increased appetite, increased adiposity, increased plasma leptin, glucose, and
cortisol, and decreased plasma insulin in response to an ad libitum feeding challenge
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(Long et al., 2013b). Lastly, diet-induced obesity of the F0 generation had effects into the
F2 generation when the F1 generation was fed a control diet. F1 ewes from the obese
mothers had greater glucose and insulin baseline concentrations and increased insulin
resistance when compared with their F1 control counterparts (Shasa et al., 2015). Lambs
in the F2 generation did not differ in birth weights between the two treatment groups but
F2 lambs from obese grandmothers had increased adiposity, hyperglycemia, and
hyperinsulinemia than their control counterparts (Shasa et al., 2015).
While there are not many studies on transgenerational effects in the human model,
there is ongoing data collection on the population subjected to the Dutch Winter Famine
(1944-45), which is now in its 6th generation and offspring are still showing some
detrimental signs, including diabetes, cardiovascular disease, and a change in metabolism
(Painter et al., 2008). The mechanisms involved in transgenerational effects are still in
question. Insults are most likely carried across generations through either an altered
maternal endocrine adaptation to pregnancy or transgenerational transmission of
epigenetic modification (Matthews et al., 2010).

Conclusion

The fetus relies completely on the dam during gestation; everything from
nutrition, oxygen, and a safe environment are provided from the time of conception until
parturition. However, maternal physiological or environmental factors may have
detrimental effects on the fetus (Barker et al., 1997).
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Arguably, the placenta is the most important factor in ensuring that the fetus
develops properly from conception to parturition. The placenta allows for nutrient and
gas exchange to the developing conceptus (Ramsey 1982) and hormone production that
can influence both fetal and maternal physiology (Gey et al., 1938; Josimovich and
MacLearn, 1962; Kaplan and Grumbach, 1964). The placenta needs an adequate blood
supply in order to provide nutrient and gas exchange; decreased blood flow is correlated
with high-risk pregnancy and inhibited fetal growth (Haggarty et al., 2002). While
vasculogenesis typically occurs primarily during the first two-thirds of gestation,
vasculogenesis can continue to increase until the end of gestation if the fetus is
experiencing limited growth (Vonnahme et al., 2004). In conjunction with
vasculogenesis, angiogenesis is fundamental to ensuring sufficient blood supply to the
placenta. Most of the factors regulating angiogenesis occur because of vasculogenesis,
including vascular endothelial growth factor (VEGF), basic fibroblast growth factor
(FGF-2), and angiopoietin protein families (ANG-1 and ANG-2) (Reynolds et al., 1988;
Millaway et al., 1989; Zheng et al., 1998).
As the fetus grows, it grows through both hyperplasia (increase in cell number)
and hypertrophy (increase in cell size). It was initially suggested that hyperplasia
occurred only in early gestation and hypertrophy occurred only in late gestation (Winick
et al., 1965). However, it has now been shown that while hyperplasia is more prevalent
during early gestation and hypertrophy is more prevalent during late gestation, both types
of cell growth exist from conception to parturition (Prior et al., 1979). The fetus can alter
its growth and endocrine environment when faced with nutrient insufficiency in order to
better prepare for postnatal life, known as the Thrifty Phenotype (Hales et al., 1992). The
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fetus can alter its growth by prioritizing nutrients to organ systems of more importance,
such as the brain and heart, at the impairment of other organ systems. Further, the fetus
can alter its endocrine environment by increasing glucocorticoids to escalate the
maturation of organs, readying them for postnatal life (Anthony et al., 2003).
Fetal growth restriction can have multi generational effects, in which the F2
generation can be affected by the F0 generation’s diet, even without a change to the F1
generation during gestation and has been shown to affect hormone levels (Pineherio et
al., 2008), increased blood pressure (Bertram et al., 2008), growth restriction caused by
synthetic glucocorticoid treatment (Long et al., 2013c), and increased adiposity,
hyperglycemia, and hyperinsulimia (Shasa et al., 2015).
Nutrition is most certainly an important factor in ensuring a fetus survives and
thrives from conception to parturition and beyond. Undernutrition and over nutrition are
both culprits in altering fetal growth and endocrine environment and the far reaching
effects of poor nutrition during gestation are still being elucidated.
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CHAPTER II
Effects of maternal nutrient restriction during early or mid-gestation
on bovine fetal growth
ABSTRACT
Primiparous Angus-cross cows (n = 38) were synchronized using a CoSynch+CIDR protocol and inseminated with semen from one of two Angus sires.
Animals were fed at 1.3 x (Control [CON]) or 0.55 x (Nutrient Restricted [NR]) of
maintenance energy and protein requirements based on BW (NRC 2000). Diets were fed
at either 1.3 x (Control [CON]) or 0.55 x (Nutrient restricted [NR]) of maintenance
energy and crude protein values based on BW (NRC 1996). A subset of animals (n = 16)
was fed either NR (n = 8) or C (n = 8) from d 30-110 of gestation. The remaining animals
(n = 22) were fed CON (n = 8) d 30-190; NR (n = 7) d 30-110 followed by CON d 110190; or CON (n = 7) d 30-110 followed by NR d 110-190. Cows were slaughtered on d
110 or d 190 of gestation, when fetal measurements and samples were taken for analysis.
Fetal weights and empty fetal weights were also reduced (P = 0.0027, P = 0.0023,
respectively) in d 110 NR animals. Fetal weights tended to be reduced (P = 0.07) in
NR/CON and CON/NR versus CON/CON cattle. Empty fetal weights were reduced (P =
0.03) in NR/CON and CON/NR versus CON/CON cattle. Abdominal and thoracic
circumferences were reduced (P = 0.0265, P = 0.0002, respectively) in d 110 NR animals
and were also reduced (P = 0.01 and P = 0.03, respectively) in NR/CON and CON/NR
versus CON/CON cattle. Brain weight as a percent of empty fetal weight (P < 0.01) was
increased in d 110 NR animals compared with d 110 CON animals. Brain weight as a
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percent of empty fetal weight was increased (P < 0.001) in NR/CON and CON/NR
versus CON/CON cattle. Fetal pancreas weight as a percent of empty fetal weight was
reduced (P = 0.06) in NR d 110 cattle. Fetal pancreas weight as a percent of empty fetal
weight was reduced (P = 0.04) in CON/NR versus CON/CON cattle (0.062 ± 0.004
versus. 0.079 ± 0.004 %) while NR/CON values (0.069 ± 0.004 %) were intermediate.
Fetal perirenal adipose as a percent of empty fetal weight was increased (P = 0.01) in NR
d 110 female fetuses. Fetal perirenal adipose as a percent of empty fetal weight was
increased (P = 0.003) in NR/CON and CON/NR versus CON/CON cattle. The data show
that maternal nutrient restriction during early or mid gestation causes asymmetrical fetal
growth restriction, regardless if the restriction is preceded or followed by a period of nonrestriction.
Keywords: fetal growth, undernutrition, fetal programming
INTRODUCTION
Fetal programming has significant effects on livestock production. In beef cattle,
animals that experience stress in-utero can have reduced skeletal growth, which can
affect carcass merit and meat production (Greenwood et al., 2005). This could be
especially problematic in heifers if they are used as breeding stock. Intrauterine growth
retardation (IUGR) is defined as any stressor on an animal that causes reduced fetal
growth during gestation; IUGR can be environmental or physiological, occur at any point
during gestation, and has permanent negative effects on the offspring’s physiology and
development (Baker et al., 1969). Specifically, environmental stress (transportation) of
the dam can lead to alteration of the hypothalamic-pituitary axis in the fetus, inhibiting
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the postnatal animal from accurate regulation of hormones involved in growth and
reproduction (Lay et al., 1997). Fetuses that undergo IUGR often exhibit asymmetrical
growth patterns, which suggests that the fetus compartmentalizes nutrients and blood
flow to the organs and structures that are most pertinent to development (Anthony et al.,
2003). Early gestation is a critical period for fetal hyperplasia (Ferrell et al., 1976), fetal
organ and tissue development, and maternal development of the placenta (Ford 1995;
Reynolds et al., 1995). The objective of this study was to determine the severity of
asymmetrical fetal growth caused by maternal nutrient restriction during early (d 30 – d
110) or midgestation (d 110 – d 190) and to what extent, if any, the effects of fetal growth
restriction could be alleviated with a trimester of non-restriction either preceding or
following the trimester of restriction.

MATERIALS AND METHODS
All animal procedures were approved by Clemson University Animal Care and
Use Committee (AUP #2013-062).

Animals and Sample Collection
Primiparous Angus-cross cows (n = 38) were synchronized using a 7 d CoSynch+CIDR protocol. On d 0, cows received an EAZI-Breed CIDR insert (Zoetis
Animal Health, New York, NY) and an injection of GnRH (100µg [IM]; Zoetis Animal
Health, New York, NY). On d 7, CIDRs were removed and cows received an injection of
PGF2α (25mg [IM]; Zoetis Animal Health, New York, NY). Cows were observed for
estrus at 0700 and 1700 h for 30 min and were inseminated by one of two AI technicians
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with sexed (d 190 fetuses) or conventional (d 110 fetuses) semen from one of two Angus
sires 12 h after first observed estrus. Any animal not observed in estrus was timed
inseminated 60 h post PGF2α injection and a GnRH injection administered. At 30 d post
breeding, pregnancy was determined via transrectal ultrasonography (Aloka 500-V with
7.5-MHz probe, Corometrics Medical Systems, Wallingford, CT). Blood samples were
collected from pregnant animals via caudal venipuncture into a 9 mL Lithium-Heparin
plasma syringe (SARSTEDT, Nümbrecht, Germany) and placed immediately on ice.
Samples were centrifuged within 2 h of collection at 2000 x g for 20 min at 4° C. After
centrifuging, the plasma was collected and stored at -20° C until analysis of metabolites.
Animals were blocked into treatment groups by BCS (Wagner et al., 1988),
shown in Figure 1. Throughout the experiment, all animals were fed a TMR (30%
soybean hulls, 20% cottonseed hulls, 17.5% peanut hulls, 17% corn screening, 12.5%
corn gluten feed, 1.5% salt, 0.5% calcium, 0.5% trace mineral, 0.5% vitamin premix:
0.65 Mcal NEm/lb, 8.9% CP) at one of two levels. Diets were fed at either 1.3 x (Control
[CON]) or 0.55 x (Nutrient restricted [NR]) of maintenance energy and crude protein
values based on BW (NRC 2000). A subset of animals (n = 16) was fed either NR (n = 8)
or C (n = 8) from d 30-110 of gestation. The remaining animals (n = 22) were fed CON
(n = 8) d 30-190; NR (n = 7) d 30-110 followed by CON d 110-190; or CON (n = 7) d
30-110 followed by NR d 110-190.
Cattle were maintained together on a dry lot with free access to water and were
fed individually once daily in the morning. Animal BW was taken weekly and used to
adjust feed allowances throughout the experiment; BCS and blood samples were taken
every 2 wk. All blood samples were collected and processed as previously described.
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All animals were harvested at the same commercial plant. Final BW, BCS, and
blood samples were collected ~24 h prior to harvest. Blood samples were collected via
jugular venipuncture into 10 mL sodium heparin, serum, and EDTA BD Vacutainers
(Becton, Dickinson and Company, Franklin Lakes, NJ). The sodium heparin and EDTA
tubes were treated exactly as previous blood samples. Serum samples were allowed to
clot for approximately 60 min at room temperature and then refrigerated overnight before
centrifuging at 2000 x g for 20 min at 4° C. After centrifuging, plasma and serum was
collected and stored at -20° C until analysis of metabolites. Cows were slaughtered and
the gravid uterus was removed and weighed. Fetal blood samples were collected from the
umbilical cord into 10 mL sodium heparin, serum, and EDTA BD Vacutainers, treated as
previously described for maternal blood, and stored at -80° C until analysis. Fetal weight,
crown rump length, abdominal circumference, and thoracic circumference were recorded.
Fetal brain, heart, liver, lungs, pancreas, kidneys, adrenals, perirenal adipose, viscera, and
longissimus dorsi muscles were collected and weights recorded at time of harvest. The
fetal heart was dissected into right and left atria, right and left ventricle, and septum; each
atria, ventricle, and septum was individually weighed and thickness measured in 3
locations and measurements averaged. The eviscerated fetus was weighed to obtain an
empty fetal weight.
Samples of caruncle, cotyledon, placentomal artery, perirenal adipose, mesenteric
adipose, large intestine, small intestine, liver, longissimus dorsi (LD) muscle, left heart
ventricle, right heart ventricle, pancreas, kidney, and adrenal tissue were collected into 2
mL CryoELITE tubes (Wheaton, Millville, NJ) and flash frozen in liquid Nitrogen. The
samples were stored at -80° C for further analysis. Identical samples were collected into
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Embedding Cassettes (EconoLab, Chambly, Quebec) and stored in 10 % Formalin for
Histology. A complete placentome was randomly collected from the uterus (cut into
eighths) and stored in 50 mL tubes with 10 % neutral buffered Formalin for histology.
All placentomes from each cow were counted and greatest and least diameter of
each at the fetal-maternal interface was recorded. The average diameter of each
placentome was used to calculate surface area of each individual placentome, total
placentome surface area, and average surface area per placentome. Placentomes were
then divided into cotyledonary and caruncular tissue, separated by tissue type, and total
caruncular and total cotyledonary tissue weights were recorded. The tissue weights were
used to calculate the ratio of fetal and maternal contribution to placentome.

Histology
All cassette samples were transferred from neutral 10 % Formalin buffer to
paraffin wax using the Leica ASP 300 Advanced Smart Processor (Leica Biosystems,
Buffalo Grove, IL). Samples were embedded in paraffin using Tissue-Tek Base Molds
(Electron Microscopy Sciences, Hatfield, PA) and stored at room temperature. The
placentome samples were kept in 50mL tubes and were transferred from neutral 10 %
Formalin to 70 % Ethanol by hand. Prior to embedding, placentomes were sliced into
approximately 3 mm thick samples and set into Embedding Cassettes. The cassettes were
then placed in the Leica ASP 300 Advanced Smart Processor transferred from 70 %
Ethanol to paraffin. Samples were then embedded in paraffin using Tissue-Tek Base
Molds and stored at room temperature.
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Perirenal adipose tissue embedded in paraffin was sectioned (5 µm) using a Leica
RM 2165 microtome (Leico Biosystems, Buffalo Grove, Illinois). Four 5 µm sections, 5
sections apart were collected for evaluation. Tissues were deparaffinized with 100%
xylene and rehydrated in graded ethanol solutions (100% – 95%). Sections were then
placed in Gill’s hematoxylin (Sigma-Aldrich, St. Louis, Missouri) for 5 minutes, rinsed
rapidly with distilled water for 2 minutes, then transferred to Ammonium water (1 mL
NH4OH in 1L H20) for 30 seconds, and then rinsed rapidly with distilled water for
another 30 seconds. Slides were then stained in Eosin Y (Sigma-Aldrich, St. Louis,
Missouri) for 3 minutes. Finally, slides were dehydrated in graded ethanol (100%),
cleared with 100% xylene, and cover slipped with Permount (Fisher Scientific). Images
of adipocytes were captured digitally at 10x magnification using iSolution Lite Version
9.4 software (Image & Microscope Technology Inc., Vancouver, British Columbia,
Canada). Two randomly chosen fields were captured per section for a total of 8 pictures
per animal. Cell diameter was evaluated on fifty randomly chosen cells per field for a
total of 400 adipocytes per animal using iSolution Lite Version 9.4 software. The
histological measure of cell diameter has been previously validated using DNA
quantification (Long et al., 2012).

Colorimetric Assays
Animals were blocked by treatment (NR or CON) and gestation group (d 110 or d
190) into assay plates. All d 190 samples (n = 22) were run separately from d 110
samples (n = 16), but within the gestation group, all treatments were represented on the
assay block. All colorimetric reagents were obtained from Pointe Scientific (Canton, MI).
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Glucose concentrations were determined by previously colorimetric assay previously
validated in our lab (Long et al., 2013a) on both maternal and fetal plasma for early and
midgestation animals. Intrassay and interassay CV of the assays were 3.5% and 3.1%,
respectively. Triglyceride concentrations were determined by colorimetric assay
previously validated in our lab (Long et al., 2013a) on both maternal and fetal serum for
early and midgestation animals. Intrassay and interassay CV for late gestation animals
were 2.4% and 3.1%, respectively. Cholesterol concentrations were determined by
colorimetric assay previously validated in our lab (Long et al., 2013a) on both maternal
and fetal serum for early and midgestation animals. Intrassay and interassay CV were
2.7% and 3.7%, respectively.

Statistics
For d 110 animals, BW and BCS change was analyzed as an ANOVA analysis
using the GLM procedure of SAS. Fetal weights and measurements, uterine weights,
placentome measures, plasma glucose in dams and fetuses at harvest, serum triglycerides
in dams and fetuses at harvest, and serum cholesterol in dams and fetuses at harvest were
analyzed using the MIXED procedure of SAS with treatment, sex, and their interaction in
the model statement. Maternal plasma glucose for d 110 animals was analyzed as a
repeated measure analysis using the MIXED procedure of SAS with treatment, day, and
their interaction in the model statement. For d 190 animals, BW and BCS changes, fetal
weights and measurements, uterine weights, placentome measures, plasma glucose in
dams and fetuses at harvest, serum triglycerides in dams and fetuses at harvest, and serum
cholesterol in dams and fetuses at harvest and adipocyte diameter were analyzed as an
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ANOVA analysis using the GLM procedure of SAS. Maternal plasma glucose was
analyzed as a repeated measure analysis using the MIXED procedure of SAS with
treatment, day, and their interaction in the model statement. A tendency was defined as P
< 0.10 and a significance difference was defined as P < 0.05

RESULTS
Maternal BW and BCS change (Table 1) showed that d 110 NR cattle had a
decrease in both BW (P < 0.0001) and BCS (P < 0.0001) from d 30 – d 110 when
compared with d 110 CON cattle. In d 190 cows, NR/CON cattle had a decrease in both
BW (P < 0.0001) and BCS (P = 0.0008) from d 30 – d 114 when compared with
CON/NR and CON cattle. A decrease in BW (P < 0.0001) and BCS (P < 0.0001)
occurred in CON/NR cows from d 114 – d 190 when compared with NR/CON and CON
cattle.
Monthly plasma glucose concentrations of d 110 cows (Figure 2) exhibited a
treatment x day effect (P = 0.0018), with the plasma concentration of the NR group
decreased (P < 0.05) compared with CON cows at d 56 and this decrease was maintained
until harvest. Maternal plasma glucose concentrations at harvest of d 110 cows (Figure 3)
were decreased (P = 0.0267) in dams on the NR diet versus dams on the CON diet at time
of harvest. Fetal plasma glucose concentrations at harvest of d 110 cows (Figure 3) were
decreased (P = 0.0137) in fetuses from dams on the NR diet versus fetuses from dams on
the CON diet. Monthly plasma glucose concentrations of d 190 cows (Figure 4) exhibited
a treatment x day effect (P = 0.0001). Cows that were nutritionally restricted on d 30 – d
110 had decreased (P < 0.05) plasma glucose compared with animals on the control diet
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during the same time period on d 58 and d 86. On d 114, both nutrient restricted groups
had decreased (P < 0.05) plasma glucose compared with the control cows. Cows that
were nutritionally restricted on d 110 – d 190 had decreased (P < 0.05) plasma glucose
compared with animals on the control diet during the same time period on d 142 and 170.
Maternal plasma glucose concentrations at harvest of d 190 cows (Figure 5) were
decreased (P = 0.0009) in dams on the NR diet, while plasma glucose concentrations
were similar between animals on the CON diet at harvest. Fetal plasma glucose
concentrations at harvest of d 190 cows (Figure 5) were decreased (P = 0.049) in fetuses
from dams on a NR diet, while plasma glucose concentrations were similar between
fetuses from dams on CON diets prior to harvest.
Maternal serum triglyceride concentrations at harvest of d 110 cows (Figure 3)
was decreased (P = 0.0029) in NR dams compared with CON dams at time of harvest.
Fetal serum triglyceride concentrations at harvest of d 110 cows (Figure 3) was decreased
(P = 0.0331) in fetuses from CON dams compared with NR dams. Maternal serum
triglyceride concentrations at harvest of d 190 cows (Figure 5) was decreased (P =
0.0078) in dams on the NR diet compared with CON diet. Fetal serum triglyceride
concentrations at harvest of d 190 fetuses (Figure 5) was decreased (P = 0.0005) in
CON/NR versus CON fetuses, however NR/CON fetuses had an increased (P < 0.05)
serum triglyceride concentration.
Maternal serum cholesterol concentrations at harvest of d 110 cows (Figure 3)
were similar to each other (P = 0.9836) regardless of treatment. Fetal serum cholesterol
concentrations at harvest of d 110 cows (Figure 3) were similar to each other (P =
0.2845) regardless of treatment. Maternal serum cholesterol concentrations at harvest of d
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190 cows (Figure 5) had a tendency to be decreased (P = 0.0976) in dams on the NR diet
compared with CON diet. Fetal serum concentrations at harvest of d 190 cows (Figure 5)
were decreased (P = 0.0194) in fetuses from dams on the NR diet compared with fetuses
from dams on the CON diet.
Fetal size and weights at d 110 of gestation are shown in Table 2. Fetal weights
and empty fetal weights were reduced (P = 0.0027, P = 0.0023, respectively) in the NR
fetuses versus CON fetuses. Crown rump length and abdominal circumference was
unaffected (P = 0.0110, P = 0.0265, respectively), while thoracic circumference was
reduced in NR fetuses versus CON fetuses (P = 0.0002). Fetal wt was increased (P =
0.0095), in male CON fetuses versus male NR fetuses and female NR and CON fetuses.
Empty fetal weight was (P = 0.01) reduced due to treatment in the NR fetuses versus the
CON fetuses. Crown rump length and thoracic circumference were (P = 0.0462, P =
0.0026, respectively) reduced due to treatment in the NR fetuses versus CON fetuses
while abdominal circumference only had a tendency (P = 0.0795) to be reduced due to
treatment in NR fetuses versus CON fetuses. Liver weights had a tendency to be
decreased (P = 0.0928) because of treatment in NR fetuses versus CON fetuses. Pancreas
weights were reduced (P = 0.0058) due to treatment in NR fetuses versus CON fetuses.
Left LD muscle weights had a tendency to be decreased (P = 0.0764) in NR fetuses
versus CON fetuses, while the right LD muscle had a tendency to be deceased in female
NR fetuses (P = 0.0668) versus female CON fetuses and male NR and CON fetuses.
Brain weight had a tendency (P = 0.0989) to be increased in male CON fetuses versus
male NR fetuses and female NR and CON fetuses. The heart, left atrium, right ventricle,
and septum were unaffected while the right atrium weight had a tendency (P = 0.086) to
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be reduced in NR fetuses versus CON fetuses and the left ventricle weight had a tendency
(P = 0.0525) to be decreased in female CON fetuses versus female NR fetuses and male
CON and NR fetuses. Ventricle wall thickness was unaffected but septum wall thickness
was increased (P = 0.0239) in NR fetuses versus CON fetuses. The right and left kidneys
(P = 0.43, P = 0.63, respectively), lungs (P = 0.14), and adrenal glands (P = 0.12) were
unaffected.
Fetal organ weights as a percent of fetal weight for d 110 fetuses are shown in
Table 3. Brain weight as a percent of fetal weight was increased (P = 0.0006) in NR male
fetuses versus CON male fetuses, with no differences seen in female fetuses. Total lung
weight as a percent of fetal weight was increased (P = 0.0463) in female fetuses versus
male fetuses. Right atrium weight as a percent of fetal weight had a tendency (P = 0.073)
to be increased in CON fetuses versus NR fetuses. Pancreas weight as a percent of fetal
weight had a tendency (P = 0.0521) to be increased in CON fetuses versus NR fetuses.
Right and left kidney weight as a percent of fetal weight had a tendency (P = 0.083 and P
= 0.0907, respectively) to be increased in female fetuses versus male fetuses. Fetal total
heart, left and right ventricles, left atrium, septum, liver, adrenal, LD muscles, viscera,
and perirenal adipose tissue weight as a percent of fetal weight were unaffected by either
maternal diet or fetal sex.
Fetal organ weights as a percent of empty fetal weight for d 110 fetuses are shown
in Table 4. Total lung weight and total heart weight as a percent of empty fetal weight
was increased (P = 0.027 and P = 0.0603) in female fetuses versus male fetuses. Pancreas
weight as a percent of empty fetal weight had a tendency (P = 0.058) to be increased in
CON fetuses versus NR fetuses. Right and left kidneys as a percent of empty fetal weight
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were increased (P = 0.044 and P = 0.0402, respectively) in female fetuses versus male
fetuses. Perirenal adipose as a percent of empty fetal weight was increased (P = 0.0066)
in female NR fetuses versus female CON fetuses, with no differences between male
fetuses. Brain weight, left and right ventricle, left and right atrium, septum, liver, adrenal,
LD muscles, and viscera weight as a percent of empty fetal weight were unaffected by
either maternal diet or fetal sex.
Fetal size and weights, as well as fetal organ weights at d 190 of gestation, are
shown in Table 5. Fetal weights tended to be reduced (P = 0.07) in NR/CON and
CON/NR versus. CON/CON cattle and empty fetal weights were reduced (P = 0.03) in
NR/CON and CON/NR versus. CON/CON cattle. Abdominal and thoracic circumference
was reduced (P = 0.01, P = 0.03, respectively) in NR/CON and CON/NR fetuses versus.
CON/CON fetuses, but crown rump length was unaffected (P = 0.32). Pancreas weight
was reduced (P = 0.02) in NR/CON and CON/NR compared with CON/CON fetuses.
Fetal liver weight was also reduced (P = 0.04) in NR/CON and CON/NR versus.
CON/CON. Right LD muscle was decreased (P = 0.006) in NR/CON and CON/NR
versus. CON/CON fetuses as well as left LD muscle (P = 0.045) in NR/CON and
CON/NR versus. CON/CON fetuses. Perirenal adipose weight tended to be reduced (P =
0.08) in NR/CON and CON/NR compared with CON/CON. Total heart weight tended to
be reduced (P = 0.07) in NR/CON and CON/NR fetuses versus. CON/CON fetuses and
left ventricular weights were reduced (P = 0.03) in NR/CON and CON/NR fetuses
versus. CON/CON fetuses but atria, the right ventricle, and septum weights were similar
between groups. Left ventricle thickness tended to be increased (P = 0.07) in NR/CON
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and CON/NR fetuses versus. CON/CON fetuses but right ventricles thickness (P = 0.36)
and septum thickness (P = 0.44) were both unaffected.
Fetal organs weights as a percent of fetal weight for d 190 fetuses are shown in
Table 6. Brain weight as a percent of fetal weight was increased (P = 0.001) in CON/NR
and NR/CON fetuses versus. CON/CON fetuses. Total heart weight as a percent of fetal
weight was increased (P = 0.01) in NR/CON and CON/NR fetuses versus. CON/CON
fetuses. Left ventricle weight as a percent of fetal weight (P = 0.004) was increased in
NR/CON and CON/NR fetuses versus. CON/CON fetuses as well as right ventricle
weight (P = 0.05) in NR/CON and CON/NR fetuses versus. CON/CON fetuses while the
left atria (P = 0.26), right atria (P = 0.35) and septum (P = 0.11) percentages were
unaffected. Pancreas weight as a percent of fetal weight tended to be decreased (P = 0.06)
in NR/CON and CON/NR fetuses compared with CON/CON fetuses. Perirenal adipose
weight as a percent of fetal weight had a tendency to be increased (P = 0.06) in NR/CON
and CON/NR fetuses compared with CON/CON fetuses. Fetal lungs, kidneys, adrenal,
liver, and LD muscle as a percentage of fetal weight were unaffected by maternal diet.
Fetal organ weights as a percent of empty fetal weight for d 190 fetuses are shown
in Table 7. Brain weight as a percent of empty fetal weight was increased (P = 0.0002) in
NR/CON and CON/NR fetuses versus. CON/CON fetuses. Total heart weight as a
percent of empty fetal weight was increased (P = 0.04) in NR/CON and CON/NR fetuses
versus. CON/CON fetuses. Left ventricle weight as a percent of empty fetal weight was
increased (P < 0.0001) in NR/CON and CON/NR fetuses versus. CON/CON as well as
right ventricle weight (P = 0.001) in NR/CON and CON/NR fetuses versus. CON/CON
fetuses. Septum weight as a percent of empty fetal weight was also increased (P = 0.04)
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in NR/CON and CON/NR fetuses versus. CON/CON. Fetal pancreas weight as a percent
of empty fetal weight was reduced (P = 0.04) in NR/CON and CON/NR fetuses versus.
CON/CON fetuses and fetal perirenal adipose as a percent of empty fetal weight was
increased (P = 0.003) in NR/CON and CON/NR fetuses versus. CON/CON fetuses.
Average adipocyte diameter in perirenal adipose tissue from d 190 fetuses was unaffected
between treatment groups (P < 0.15)
Uterus weights and placenta characteristics for d 110 and d 190 fetuses are shown
in Table 8. In d 190 and d 110 fetuses, no differences were found between gravid uterus
weights (P = 0.4, P = 0.13, respectively) and while there was no difference found
between empty uterus weights of d 190 fetuses (P = 0.732), d 110 fetuses showed a
tendency for decreased empty uterus weight in NR fetuses versus CON fetuses (P =
0.0887). In d 110 fetuses, total placentome weight and total caruncle weight was
unaffected, while total cotyledonary weight was increased (P = 0.0069) in NR fetuses
versus CON fetuses. Ratio of cotyledonary weight to caruncle weight had a tendency (P
= 0.0879) to be increased in NR fetuses versus CON fetuses. Number of placentomes
was increased (P = 0.0282) in NR fetuses versus CON fetuses. Average surface area per
placentome did not differ between treatment groups, but total placentome surface area
was increased (P = 0.0281) in NR fetuses versus CON fetuses. In d 190 fetuses, total
placentome weight (P = 0.05) and total caruncle weight (P = 0.07) was decreased in
NR/CON animals versus. CON/CON and CON/NR animals. Total cotyledonary weight
was increased (P = 0.01) in CON/NR fetuses versus. CON/CON and NR/CON. Ratio of
cotyledonary weight to caruncle weight was increased (P = 0.01) in NR/CON and
CON/NR animals versus. CON/CON. Number of placentomes did not differ between
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treatment groups. Average surface area per placentome did not differ, but total
placentome surface area had a tendency to be increased (P = 0.09) in CON/NR animals
versus CON and NR/CON.
Adipocyte diameter did not differ (P = 0.15) regardless of treatment in d 190
fetuses (Figure 6).

DISCUSSION
To the authors’ knowledge, this is the first study with maternal nutrient restriction
during early or mid gestation in cattle without subsequent realimentation with fetal
endpoints. Previous studies have shown in multiple mammal species that maternal
nutrient restriction during early and midgestation can lead to intrauterine growth
restriction (IUGR) exhibited by asynchronous organ growth (i.e., enlarged hearts and
brains) (Schoknecth et al., 1994; McMillen et al., 2001; Vonnahme et al., 2003; Platz et
al., 2008; Long et al., 2009), even with realimentation following the period of nutrient
restriction. This study revealed asynchronous organ growth in fetuses from nutrient
restricted dams regardless of which trimester the nutrient restriction took place. Further,
IUGR fetuses are more likely to develop metabolic issues such as obesity, glucose/insulin
dysregulation, and cardiovascular disease in postnatal life (Poore et al., 2002; Gardner et
al., 2005; Gilbert et al., 2005). Other studies with maternal nutrient restriction
(Vonnahme et al., 2007; Camacho et al., 2013) have shown similar maternal BW and
BCS loss in restricted cows as seen in this study. Body weight and BCS loss was more
significant in this study than other early gestation maternal nutrient restriction
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(Vonnahme et al., 2007; Camacho et al., 2013), despite similar restriction levels because
our diet did not incorporate nutrition requirements for pregnancy.
Plasma glucose was decreased in NR dams and fetuses at both d 110 and d 190 of
gestation. This data is consistent with that of Ford et al. (2007) who observed decreased
plasma glucose concentrations in ewes on 50% nutrient restricted diet during the first half
(d 28 – 78) of gestation. A similar trend was seen in a nutrition study utilizing obese
pregnant ewes. Obese ewes and their fetuses had the higher plasma glucose levels,
reflecting their increased nutritional status. Control ewes and their fetuses had the lower
plasma glucose levels of the study, reflecting their comparatively lower nutritional status
(Tuersunjiang et al., 2013). In contrast, a study from that of Long et al. (2009), showed
that not all NR cattle and fetuses would exhibit decreased plasma glucose concentrations,
though this was speculated to result from increased age of the cattle and therefore an
increased ability to adequately partition nutrients to maintain normal fetal growth.
Serum triglycerides were decreased in NR dams and fetuses at d 110 and d 190 of
gestation. Ma et al. (2011) also showed significant decreases of triglyceride
concentrations in fetuses from nutrient restricted ewes versus control ewes during the first
half of gestation (d 78). In a study by Zhu et al. (2010b), obese ewes and their fetuses had
increased triglyceride concentrations relative to their control counterparts as a reflection
of their increased nutritional status. In contrast, pregnant rats fed a high fat diet and/or
supplemented with lipopolysaccharides (Hao et al., 2014) showed no changes in maternal
serum triglyceride levels from the control group.
While the fetus can synthesize cholesterol on its own, there is still transport of
maternal cholesterol to the fetal environment (Woollett 2011). During early gestation,
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when demand for growth is lower, cholesterol is not as compulsory as is indicated by the
similarities in serum cholesterol concentration at harvest in either maternal or fetal serum,
regardless of treatment in d 110 animals. This trend was similar to a sheep study by Ma et
al. (2011), where fetal cholesterol concentrations from nutrient restricted or control ewes
was unaffected. By midgestation (d 110 – d 190) as demand for cholesterol increases,
nutrient restricted animals are less likely to be able to meet the demand, as seen in the
significant decrease of serum cholesterol in nutrient restricted d 190 dams and fetuses.
With decreased maternal cholesterol, there is decreased birth weight and a possibility of
microcephaly in children (Edison et al., 2007). Other studies have found that mice
exhibited reduced growth rates in nutrient restricted dams (McConihay et al., 2000) and
in humans; there is a positive correlation between intrauterine growth restriction and low
serum cholesterol (Sattar et al., 1999; Wadsack et al., 2007).
Placentome number was increased in d 110 nutrient restricted animals, which is in
contrast to data in Long et al. (2009) where nutrient status did not affect placentome
number in early gestation cattle. Increased placentome number also contrasts with data
presented by Vonnahme et al. (2006), in which Baggs ewes restricted during the first half
of gestation (d 28 – 78) had similar placentome number to control ewes. However the
same study showed an increased placentome number in twin bearing, nutrient restricted
Baggs ewes (sheep selected based on nomadic lifestyle). Placentome number was
unaffected in d 190 cattle, which is in contrast to data in Long et al. (2009), where
nutrient restricted animals had decreased placentome numbers, but is in agreement to data
presented by Ma et al. (2011) in which nutrient restriction during early gestation had no
effect on placentome numbers in sheep. Total placentome surface area was increased for
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d 110 nutrient restricted cattle and d 190 cattle that were restricted from d 110 – d 190,
which contrasts with data presented in Long et al. (2009). In the present study we
presented a decreased placentome weight in d 190 animals that were restricted d 30 – 110
of gestation, which is in contrast to data presented by Ma et al. (2011) in which ewes that
were nutrient restricted during early gestation had similar placentome weights after a
period of realimentation. In contrast to both the present study and Ma et al. (2011), work
done on the sheep model by Vonnahme et al. (2006) showed an increase in placentome
weight in twin-bearing, nutrient restricted, and twin-bearing nutrient restricted ewes
during early gestation, except the Baggs ewe model showed a decrease in placentome
weight in nutrient restricted single bearing ewes compared with single bearing control fed
ewes.
Caruncle weights for d 110 cows were unchanged between nutrient restricted and
control treatments, consistent with data reported by Long et al., (2009). Caruncle weights
were decreased in d 190 animals that were restricted d 30 – 110 of gestation, which
contrasts with the data of Long et al. (2009) and Rasby et al. (1990), in which caruncular
weight was unaffected based on diet. However, decreased caruncular weight was reported
in ewes carrying twin fetuses versus ewes carrying singleton fetuses (van der Linden et
al., 2012), because twin-bearing ewes were at a higher nutrient disadvantage.
Cotyledonary weights were increased for nutrient restricted d 110 cows, which is in
contrast to the data of Long et al. (2009). Cotyledonary weights were increased for d 190
cows when restricted from d 110 – 190, which contrasts with data produced by van der
Linden et al. (2010), in which twin-bearing ewes (higher nutrient disadvantage) had
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decreased cotyledonary weights. However, Rasby et al. (1990) did show an increase in
cotyledonary weight for nutrient restricted cattle versus control fed cattle.
The placenta, and therefore nutrient transport, can respond in one of two ways
when exposed to maternal nutrient restriction. The placental nutrient sensing model and
the fetal nutrient demand model work through entirely different mechanisms, result in
two different placental responses, but can also occur simultaneously. In the placental
nutrient sensing model (Jansson et al., 2006a; Jansson et al., 2006b; Rosario et al., 2011),
the placenta responds to decreased maternal nutrition by downregulation of placental
nutrient transporters. In the fetal demand model (Constancia et al., 2005; Sibley et al.,
2010; Angiolini et al., 2011), the fetus signals to the placenta to upregulate placenta
nutrient transporters. The opposing action of these two models and its subsequent results
can differ based on the species as well as the time, duration, and severity of the nutrient
restriction.
There was a slight sex effect in d 110 animals, with the kidneys and lungs as a
percent of fetal weight of male fetuses being decreased compared with female fetuses.
While we can only speculate on the cellular composition of the kidneys, previous studies
have shown decreased glomerular number and glomeruli per gram of tissue in nutrient
restricted fetuses (Long et al., 2009) and that inefficiency of nutrient transport across the
placenta can decrease nephron numbers by as much as 30% in rats, rabbits, pigs, and
sheep. This decrease in nephron number correlates with a decrease in filtration efficiency
of the kidneys (Merlet-Benichou et al., 1994; Bassan et al., 2000; Bauer et al., 2002).
Furthermore, nutrient restriction of ewes during the first half of pregnancy showed a
reduction in glomeruli at d 135 gestation in male fetuses (Gilbert et al., 2007). Lastly,
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male fetuses from 50% nutrient restricted ewes during the first half of gestation showed
reduced nephron numbers, which correlated with increased blood pressure (Gilbert et al.,
2005). Again, while we can only conjecture as to the molecular composition of the lungs,
previous studies in rats have shown that maternal nutrient restriction have led to altered
lung structure of the offspring (Rehan et al., 2014) including decreased alveolar numbers
and increased septal thickening in response to increased glucocorticoids caused by the
stress of the dam’s nutrient restriction.
In d 110 animals, fetal weight, brain weight, left ventricle weight, brain weight as
a percent empty fetal weight, and perirenal adipose tissue as a percent of empty fetal
weight exhibited a treatment x sex effect, in which fetuses that were both male and
nutrient restricted showed increased evidence of growth restriction. Typically, male
fetuses grow quicker and heavier than female fetuses (Pederson 1980) and are therefore
more susceptible to nutrient restriction. This variance in growth rates could mean that
nutrient restriction may have differing levels of severity depending on the sex of the
fetus, or that nutrient restriction during a particular time of gestation may have increased
effects on one of the two sexes.
Increased percentage of perirenal adipose tissue in nutrient restricted fetuses has
been indicated by the “thrifty phenotype”, with offspring from undernourished dams
being programmed for decreased nutrients in postnatal life if subjected to undernutrition
during gestation (Hales and Barker, 2001). This increase in relative perirenal adipose
tissue depots has been reported in twin bearing ewes on a 70% restricted diet during
gestation (Edwards et al., 2005). Twin fetuses from restricted ewes were potentially
more severely restricted than singleton fetuses from restricted ewes because of increased
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nutrient partitioning in utero. This increase in adipose percentage may alter appetite
regulation in the postnatal animal, caused by changes in endocrine secretions from the
adipose tissue (Wang et al., 2008). This alteration of appetite and increased adiposity
leads to further metabolic disorders such as insulin and glucose dysregulation, also
observed in sheep that were restricted during early (d 28 - 78) gestation (George et al.,
2012).
Average adipocyte diameter of d 190 fetuses was unaffected, regardless of
treatment group, which is in contrast to Long et al. (2012), in which nutrient restricted
fetuses had slightly increased average adipocyte diameter and suggested that this could be
because of a depot specific effect. However, the fetuses in this project were sampled at d
190 instead of sampling from the postnatal animal as done in Long et al. (2012).
Furthermore, the cattle in this study were not realimented as the cattle in the previously
reported study, which could be why no changes in adipocyte diameter were observed.
In conclusion, while it has been previously illuminated that nutrient restriction
during early gestation causes IUGR and decreased fetal development, midgestation
nutrient restriction has now been shown to cause the same damaging effects to the same
extent, even with no nutritional stress during early gestation. Realimentation of animals
after a period of nutrient restriction alleviates some of the damaging results of nutrient
restriction, but without realimentation this study shows that the effects of nutrient
restriction cannot be overcome. Nutrient restriction without subsequent realimentation
has a higher level of detriment on uterine characteristics, further limiting the nutrient
transport from dam to fetus.
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Table 1: Maternal BW (kg) and BCS change throughout gestation for d 110 and d 190
animals1
d 110 animals
Item
n
Initial BW
d 30 - 110 BW
Initial BCS
d 30 - 110

CON
8
573.8 ± 47.0
11.88 ± 3.33
5.81 ± 0.49
0.125 ± 0.169

NR
8
553.9 ± 61.3
-53.52 ± 3.14
5.72 ± 0.63
-1.222 ± 0.159

P value

Item

CON

NR/CON

CON/NR

n
Initial BW
Initial BCS
d 30 – 114 BW

8
537.4 ± 21.8
5.31 ± 0.16
11.70 ± 4.36

7
537.1 ± 23.3
5.57 ± 0.18
-50.19 ± 4.66

d 30 – 114 BCS

0.12 ± 0.20

-1.14 ± 0.21

7
522.0 ± 23.3
5.21 ± 0.18
12.91 ± 4.66
0.00 ±
0.21
-77.33 ±
4.77

< 0.0001
< 0.0001

d 190 animals
P value
0.866
0.351
< 0.0001
0.0008

d 114 – 190
14.48 ± 4.46
19.28 ± 4.77
< 0.0001
BW
d 114 – 190
-0.06 ± 0.14
0.28 ± 0.15
-1.28 ± 0.15
< 0.0001
BCS
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient
restricted cows fed 0.55 x of NRC NEm and CP recommendations
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Table 2: Fetal measurements and selected organ weights of male and female fetuses on d 110 of gestation
from CON and NR cattle1
Item
CON

NR

P value
trt

sex

trt*sex

Male

Female

Male

Female

n

6

2

6

2

Fetal wt kg
Empty Fetal
Weight
Crown rump
length, cm
Abdominal
circumference, cm
Thoracic
circumference, cm

0.71 ± 0.01

0.62 ± 0.01

0.59 ± 0.01

0.63 ± 0.02

0.03

0.20

0.01

0.54 ± 0.01

0.49 ± 0.02

0.47 ± 0.01

0.46 ± 0.02

0.01

0.10

0.31

26.6 ± 0.3

26.2 ± 0.6

25.3 ± 0.3

25.2 ± 0.6

0.05

0.64

0.76

20.3 ± 0.9

19.5 ± 1.6

17.4 ± 0.9

17.1 ± 1.6

0.08

0.68

0.86

18.8 ± 0.2

18.5 ± 0.4

17.2 ± 0.2

17.5 ± 0.4

0.003

0.91

0.41

Viscera wt, g

53.8 ± 6.0

53.5 ± 10.5

45.5 ± 6.0

49.8 ± 10.5

0.50

0.82

0.79

Liver wt, g

24.6 ± 0.8

21.5 ± 1.4

20.9 ± 0.8

21.0 ± 1.4

0.09

0.22

0.19

Pancreas, g

0.61 ± 0.07

0.91 ± 0.12

0.41 ± 0.07

0.44 ± 0.12

0.01

0.14

0.22

Total lung wt, g

20.1 ± 1.1

17.9 ± 2.0

18.3 ± 1.1

21.3 ± 2.0

0.65

0.80

0.14

Right kidney wt, g

2.8 ± 0.1

2.8 ± 0.3

2.4 ± 0.1

2.9 ± 0.3

0.60

0.40

0.43

Left kidney wt, g

2.82 ± 0.23

2.92 ± 0.40

2.5 ± 0.2

3.00 ± 0.40

0.78

0.43

0.63

Adrenal wt, g

0.24 ± 0.21

0.99 ± 0.36

0.56 ± 0.21

0.32 ± 0.36

0.57

0.42

0.12

Brain wt, g
Right LD muscle,
g

12.4 ± 0.3

12.6 ± 0.6

12.9 ± 0.3

11.1 ± 0.6

0.34

0.15

0.07

6.3 ± 0.2

5.4 ± 0.4

4.7 ± 0.2

5.0 ± 0.4

0.02

0.39

0.10

Left LD muscle, g

6.4 ± 0.3

5.2 ± 0.5

4.7 ± 0.3

5.1 ± 0.5

0.08

0.41

0.10

Heart wt, g

5.5 ± 0.3

5.2 ± 0.6

4.7 ± 0.3

5.2 ± 0.6

0.45

0.81

0.50

Left atrium wt, g

0.55 ± 0.06

0.26 ± 0.11

0.32 ± 0.06

0.32 ± 0.11

0.40

0.16

0.16

Right atrium wt, g
Left ventricle wt,
g
Right ventricle wt,
g

0.45 ± 0.04

0.38 ± 0.07

0.27 ± 0.04

0.33 ± 0.07

0.09

0.87

0.32

1.36 ± 0.1

0.82 ± 0.2

1.05 ± 0.1

1.41 ± 0.2

0.50

0.65

0.05

0.94 ± 0.15

0.09 ± 0.26

1.03 ± 0.15

1.04 ± 0.26

0.59

0.96

0.91

Septum wt, g
Avg left venticle
thickness, mm

1.34 ± 0.08

0.8 ± 0.1

1.22 ± 0.08

1.1 ± 0.1

0.52

0.05

0.13

4.1 ± 0.2

3.1 ± 0.5

4.5 ± 0.2

4.9 ± 0.4

0.02

0.41

0.11

Avg right venticle
3.0 ± 0.1
3.0 ± 0.4
3.9 ± 0.1
3.4 ± 0.3
0.05
0.40
0.43
thickness, mm
Avg septum
4.0 ± 0.1
3.7 ± 0.4
4.7 ± 0.1
4.7 ± 0.3
0.02
0.72
0.57
thickness, mm
Perirenal adipose
1.69 ± 0.20 1.57 ± 0.34
1.47 ± 0.20
1.57 ± 0.34
0.72
0.98
0.70
wt, g
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Table 3: Measurements and selected organ weights of male and female fetuses on d 110 of gestation
from CON and NR cattle1
Item
Female

P
value

Male

sex

trt*se
x

0.03

0.20

0.01

25.3 ± 0.3

0.05

0.64

0.75

20.3 ± 0.9

17.4 ± 0.9

0.08

0.68

0.86

17.5 ± 0.4

18.8 ± 0.2

17.2 ± 0.2

0.003

0.91

0.41

49.8 ± 10.5

53.8 ± 6.0

45.5 ± 6.0

0.50

0.82

0.79

21.0 ± 1.4

24.6 ± 0.8

20.9 ± 0.8

0.09

0.22

0.19

0.91 ± 0.12

0.44 ± 0.12

0.61 ± 0.07

0.41 ± 0.07

0.01

0.14

0.22

17.9 ± 2.0

21.3 ± 2.0

20.1 ± 1.1

18.3 ± 1.1

0.65

0.80

0.14

2.8 ± 0.3

2.9 ± 0.3

2.8 ± 0.1

2.4 ± 0.1

0.60

0.40

0.43

2.9 ± 0.4

3.0 ± 0.4

2.8 ± 0.2

2.5 ± 0.2

0.78

0.43

0.63

Adrenal wt, g

0.99 ± 0.36

0.32 ± 0.36

0.24 ± 0.21

0.56 ± 0.21

0.57

0.42

0.12

Brain wt, g
Rt LD muscle,
g
Lt LD muscle,
g

12.6 ± 0.6

11.1 ± 0.6

12.4 ± 0.3

12.9 ± 0.3

0.34

0.15

0.07

5.4 ± 0.4

5.0 ± 0.4

6.3 ± 0.2

4.7 ± 0.2

0.02

0.39

0.01

5.2 ± 0.5

5.1 ± 0.5

6.4 ± 0.3

4.7 ± 0.3

0.08

0.41

0.10

5.2 ± 0.6

5.2 ± 0.6

5.5 ± 0.3

4.7 ± 0.3

0.45

0.81

0.51

Lt atrium wt, g

0.26 ± 0.11

0.32 ± 0.11

0.55 ± 0.06

0.32 ± 0.06

0.40

0.16

0.16

Rt atrium wt, g
Lt ventricle wt,
g
Rt ventricle wt,
g

0.38 ± 0.07

0.33 ± 0.07

0.45 ± 0.04

0.27 ± 0.04

0.09

0.87

0.32

0.82 ± 0.2

1.41 ± 0.2

1.36 ± 0.1

1.05 ± 0.1

0.50

0.65

0.05

0.09 ± 0.26

1.04 ± 0.26

0.94 ± 0.15

1.03 ± 0.15

0.59

0.96

0.91

CON

NR

CON

NR

2

2

6

6

Fetal wt kg

0.62 ± 0.01

0.63 ± 0.02

0.71 ± 0.01

0.59 ± 0.01

CRL, cm
Abdominal
circ, cm
Thoracic circ,
cm

26.2 ± 0.6

25.2 ± 0.6

26.6 ± 0.3

19.5 ± 1.6

17.1 ± 1.6

18.5 ± 0.4

Viscera wt, g

53.5 ± 10.5

Liver wt, g

21.5 ± 1.4

Pancreas, g
Total lung wt,
g
Rt kidney wt, g
Lt kidney wt, g

n

Heart wt, g

trt

Septum wt, g
0.8 ± 0.1
1.1 ± 0.1
1.34 ± 0.08 1.22 ± 0.08
0.52
0.05
0.13
Avg lt venticle
3.1 ± 0.5
4.9 ± 0.4
4.1 ± 0.2
4.5 ± 0.2
0.02
0.41
0.11
thickness, mm
Avg rt venticle
3.0 ± 0.4
3.4 ± 0.3
3.0 ± 0.1
3.9 ± 0.1
0.05
0.40
0.43
thickness, mm
Avg septum
3.7 ± 0.4
4.7 ± 0.3
4.0 ± 0.1
4.7 ± 0.1
0.02
0.72
0.57
thickness, mm
Perirenal
1.57 ± 0.34
1.57 ± 0.34
1.69 ± 0.20 1.47 ± 0.20
0.72
0.98
0.70
adipose wt, g
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows
fed 0.55 x of NRC NEm and CP recommendations
Rt: right
Lt: left
circ: circumference
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Table 4: Organ weights divided by weight of fetus (FW) at d 110 of gestation from CON and NR cattle1
Item
Female
CON

Male
NR

CON

P value
NR

trt

sex

n
2
2
6
6
Brain wt,
0.020 ± 0.001
0.017 ± 0.001
0.017 ± 0.001
0.022 ± 0.001
0.29 0.52
g/FW, g
Lung wt,
0.035 ± 0.003
0.033 ± 0.003
0.026 ± 0.001
0.031 ± 0.001
0.59 0.05
g/FW, g
Heart wt,
0.009 ± 0.001
0.008 ± 0.001
0.007 ± 0.001
0.008 ± 0.001
0.60 0.10
g/FW, g
Lt ventricle
0.0015 ± 0.0004 0.0022 ± 0.0004 0.0018 ± 0.0002
0.0017 ± 0.0002
0.42 0.85
wt, g/FW, g
Rt venticle
0.0018 ± 0.0004 0.0016 ± 0.0004 0.0011 ± 0.0002
0.0017 ± 0.0002
0.60 0.48
wt, g/FW, g
Lt atrium wt,
0.0008 ± 0.0002 0.0005 ± 0.0002 0.0006 ± 0.0001
0.0005 ± 0.0001
0.28 0.90
g/fetal wt, g
Right atrium
0.00061 ±
0.00050 ±
0.0007 ± 0.0001 0.0005 ± 0.0001
0.07 0.49
wt, g/FW, g
0.00006
0.00006
Septum wt,
0.0017 ± 0.0002 0.0018 ± 0.0002 0.0017 ± 0.0001
0.0020 ± 0.0001
0.44 0.48
g/FW, g
Liver wt,
0.034 ± 0.002
0.033 ± 0.002
0.034 ± 0.001
0.035 ± 0.001
0.94 0.62
g/FW, g
Pancreas wt,
0.0013 ± 0.0002 0.0007 ± 0.0002 0.0009 ± 0.0001
0.0007 ± 0.0001
0.05 0.31
g/FW, g
Rt kidney
0.0051 ± 0.0006 0.0047 ± 0.0006 0.0038 ± 0.0003
0.0042 ± 0.0003
1.00 0.08
wt, g/FW, g
Lt kidney
0.0054 ± 0.0006 0.0048 ± 0.0006 0.0037 ± 0.0004
0.0043 ± 0.0004
1.00 0.09
wt, g/FW, g
Adrenal wt,
0.0014 ± 0.0005 0.0005 ± 0.0005 0.0003 ± 0.0003
0.0009 ± 0.0003
0.68 0.52
g/FW, g
Lt LD
muscle,
0.010 ± 0.001
0.008 ± 0.001
0.0085 ± 0.0006
0.0080 ± 0.0006
0.23 0.41
g/FW, g
Rt LD
muscle,
0.010 ± 0.001
0.008 ± 0.001
0.009 ± 0.001
0.008 ± 0.001
0.13 0.31
g/FW, g
Viscera wt,
0.074 ± 0.015
0.078 ± 0.015
0.078 ± 0.009
0.077 ± 0.015
0.92 0.90
g/FW, g
Perirenal
adipose wt,
0.927 ± 0.082
0.788 ± 0.082
0.919 ± 0.047
0.706 ± 0.047
0.02 0.52
g/FW, g
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
CRL: crown rump length
Rt: right
Lt: left
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trt*
sex
<0.01
0.22
0.14
0.35
0.30
0.63
0.49
0.58
0.62
0.27
0.43
0.31
0.14
0.52
0.31
0.82
0.59

Table 5: Fetal measurements and selected organ weights on d 190 of gestation from CON, NR/CON, and
CON/NR cows1
Item
n
Fetal wt, kg

CON

NR/CON

CON/NR

P value

8
10.3 ± 0.40

7
009.1 ± 0.50

7
8.9 ± 0.5

0.08

8.5 ± 0.4

007.2 ± 0.40

7.2 ± 0.4

0.03

CRL, cm

65.6 ± 1.40

062.4 ± 1.50

63.5 ± 1.5

0.32

Abdominal circ, cm

47.3 ± 0.90

043.5 ± 0.90

43.9 ± 0.90

0.02

Thoracic circ, cm

45.6 ± 0.80

042.7 ± 0.90

42.5 ± 0.90

0.03

Brain wt, g

106.5 ± 4.400

097.3 ± 4.70

100.9 ± 4.700

0.37

Heart wt, g

77.2 ± 5.00

065.2 ± 5.40

59.9 ± 5.40

0.08

Lt atrium wt, g

4.9 ± 0.6

005.1 ± 0.60

5.7 ± 0.6

0.65

Rt atrium wt, g

5.9 ± 0.8

003.9 ± 0.80

4.8 ± 0.8

0.23

Lt ventricle wt, g

21.4 ± 0.90

017.9 ± 0.90

18.9 ± 0.90

0.04

Rt ventricle wt, g

19.7 ± 1.40

016.7 ± 1.5

16.9 ± 1.50

0.28

Septum wt, g

18.2 ± 1.10

018.2 ± 1.20

17.2 ± 1.2

0.80

Avg lt venticle thickness, mm

10.3 ± 0.30

011.2 ± 0.40

11.4 ± 0.40

0.08

Fetal empty carcass wt, kg

8.4 ± 0.5

007.4 ± 0.50

7.8 ± 0.5

0.37

10.3 ± 0.40

011.1 ± 0.40

10.7 ± 0.40

0.44

Liver wt, g

315.2 ± 13.60

267.0 ± 14.6

271.0 ± 14.60

0.05

Lung wt, g

238.3 ± 19.250

218.2 ± 20.6

226.1 ± 20.60

0.78

Pancreas wt, g

6.3 ± 0.4

005.6 ± 0.40

4.5 ± 0.4

0.03

Rt kidney wt, g

39.2 ± 2.50

038.4 ± 2.60

35.7 ± 2.60

0.61

Lt kidney wt, g

42.3 ± 2.60

038.8 ± 2.80

35.8 ± 2.80

0.26

1.6 ± 0.2

001.7 ± 0.20

1.2 ± 0.2

0.21

Lt LD muscle, g

110.5 ± 7.000

093.9 ± 7.50

83.29 ± 7.50

0.05

Rt LD muscle, g

113.8 ± 6.700

091.6 ± 7.20

78.9 ± 7.20

0.01

Viscera wt, g

595.1 ± 38.60

557.8 ± 41.3

503.3 ± 41.30

0.29

Avg rt venticle thickness, mm
Avg septum thickness, mm

Adrenal wt, g

34.3 ± 1.70
028.3 ± 1.90
30.8 ± 1.90
0.09
Perirenal adipose wt, g
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
CRL: crown rump length
circ: circumference
Rt: right
Lt: left
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Table 6: Fetal organ weights as a percent of fetal weight (FW) on d 190 of gestation from CON, NR/CON,
and CON/NR cows1
Item

CON

NR/CON

CON/NR

8

7

7

1.00 ± 0.02

1.08 ± 0.02

1.15 ± 0.02

0.002

Total lung wt, g/FW, g

2.3 ± 0.1

2.3 ± 0.1

2.4 ± 0.1

0.76

Heart wt, g/fetal wt, g

0.69 ± 0.01

0.75 ± 0.01

0.76 ± 0.01

0.01

Left ventricle wt, g/FW, g

0.201 ± 0.004

0.209 ± 0.005

0.228 ± 0.005

0.01

Right venticle wt, g/FW, g

0.178 ± 0.005

0.194 ± 0.006

0.198 ± 0.006

0.06

Left atrium wt, g/FW, g

0.047 ± 0.006

0.056 ± 0.006

0.062 ± 0.006

0.27

Right atrium wt, g/FW, g

0.055 ± 0.005

0.044 ± 0.005

0.052 ± 0.005

0.35

Septum wt, g/FW, g

0.172 ± 0.008

0.198 ± 0.008

0.191 ± 0.008

0.12

2.99 ± 0.08

2.95 ± 0.08

3.05 ± 0.08

0.75

0.065 ± 0.004

0.057 ± 0.004

0.049 ± 0.004

0.07

Right kidney wt, g/FW, g

0.37 ± 0.02

0.42 ± 0.02

0.39 ± 0.02

0.37

Left kidney wt, g/FW, g

0.40 ± 0.02

0.42 ± 0.02

0.40 ± 0.02

0.72

0.015 ± 0.002

0.019 ± 0.002

0.013 ± 0.002

0.18

Left LD muscle, g/FW, g

1.1 ± 0.1

1.1 ± 0.1

0.9 ± 0.1

0.52

Right LD muscle, g/FW, g

1.1 ± 0.1

1.1 ± 0.1

0.9 ± 0.1

0.19

Viscera wt, g/FW, g

5.7 ± 0.3

6.1 ± 0.3

5.7 ± 0.3

0.56

n
Brain wt, g/FW, g

Liver wt, g/FW, g
Pancreas wt, g/FW, g

Adrenal wt, g/FW, g

P value

0.06
Perirenal adipose wt, g/FW, g
0.31 ± 0.01
0.35 ± 0.01
0.34 ± 0.01
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Table 7: Fetal organ weights as a percent of empty fetal weight (EFW) on d 190 of gestation from
CON, NR/CON, and CON/NR cows1
Item

CON

NR/CON

Brain wt, g/EFW, g

8
1.21 ± 0.03

7
1.38 ± 0.03

7
1.44 ± 0.03

< 0.01

Lung wt, g/EFW, g

2.83 ± 0.20

2.98 ± 0.21

3.08 ± 0.21

0.69

Heart wt, g/EFW, g

0.82 ± 0.03

0.92 ± 0.03

0.93 ± 0.03

0.04

Lt ventricle wt, g/EFW, g

0.24 ± 0.01

0.28 ± 0.01

0.28 ± 0.01

<0.01

Rt venticle wt, g/EFW, g

0.21 ± 0.01

0.25 ± 0.01

0.24 ± 0.01

0.002

Lt atrium wt, g/EFW, g

0.06 ± 0.01

0.07 ± 0.01

0.08 ± 0.01

0.16

Rt atrium wt, g/EFW, g

0.07 ± 0.04

0.13 ± 0.04

0.07 ± 0.04

0.45

Septum wt, g/EFW, g

0.21 ± 0.01

0.25 ± 0.01

0.24 ± 0.01

0.04

3.7 ± 0.1

3.7 ± 0.1

3.8 ± 0.1

0.79

Pancreas wt, g/EFW, g

0.08 ± 0.01

0.07 ± 0.01

0.06 ± 0.01

0.05

Rt kidney wt, g/EFW, g

0.46 ± 0.03

0.53 ± 0.03

0.49 ± 0.03

0.25

Lt kidney wt, g/EFW, g

0.50 ± 0.03

0.54 ± 0.03
0.023 ± 0.002

0.50 ± 0.030

0.58

0.016 ± 0.002

0.13

n

Liver wt, g/EFW, g

Adrenal wt, g/EFW, g

0.019 ± 0.002

CON/NR

P value

Lt LD muscle, g/EFW, g

1.3 ± 0.1

1.3 ± 0.1

1.2 ± 0.1

0.52

Rt LD muscle, g/EFW, g

1.34 ± 0.09

1.33 ± 0.09

1.13 ± 0.09

0.22

Viscera wt, g/EFW, g

7.04 ± 0.41

7.76 ± 0.44

7.08 ± 0.44

0.43

< 0.01
Perirenal adipose wt, g/EFW, g
0.38 ± 0.01
0.43 ± 0.01
0.44 ± 0.01
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows
fed 0.55 x of NRC NEm and CP recommendations
EFW: empty fetal weight
Rt: right
Lt: left
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Table 8: Uterus weights and placenta characteristics on d 190 and d 110 of gestation CON or NR cows1
d 110
Item

CON

NR

n

8

8

Full uterus wt, kg

4.7 ± 0.2

5.3 ± 0.2

0.133

Empty uterus wt, kg

1.5 ± 0.1

1.2 ± 0.1

0.176

Total placentome wt, kg

0.53 ± 0.06

0.66 ± 0.06

0.205

Total caruncle wt, kg

0.31 ± 0.05

0.32 ± 0.05

0.928

Total cotyledonary wt, kg

0.22 ± 0.02

0.33 ± 0.02

0.007

Cot wt, kg/Car wt, kg

0.81 ± 0.14

1.194 ± 0.143

0.087

Placentomes, n

54.5 ± 6.5

77.8 ± 6.5

0.028

526.9 ± 63.5

676.3 ± 63.5

0.123

34952 ± 4925

52343 ± 4925

0.028

CON

NR/CON

Average placentome SA, mm
Total placentome SA, mm

2

2

P value

d 190
Item
n

CON/NR

P value

8

7

7

Full uterus wt, kg

23.2 ± 1.2

20.6 ± 1.3

21.6 ± 1.3

0.401

Empty uterus wt, kg

2.6 ± 0.1

2.5 ± 0.1

2.4 ± 0.1

0.732

Total placentome wt, kg

3.1 ± 0.1

2.7 ± 0.1

3.3 ± 0.1

0.056

Total caruncle wt, kg

1.8 ± 0.1

1.4 ± 0.1

1.7 ± 0.1

0.07

Total cotyledonary wt, kg

1.29 ± 0.07

1.31 ± 0.07

1.60 ± 0.07

0.017

Cot wt, kg/Car wt, kg

0.72 ± 0.04

0.91 ± 0.05

0.92 ± 0.05

0.02

Placentomes, n
Avg placentome SA mm2
Total placentome SA, mm

2

103.3 ± 5.2

102.1 ± 5.5

106.5 ± 5.5

0.846

1724.3 ± 105.2

1816.3 ± 112.50

1916.7 ± 73.000

0.473

177311 ± 612100

18422 ± 654400

197913 ± 654400

0.093

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient
restricted cows fed 0.55 x of NRC NEm and CP recommendations
SA: Surface area
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Figure 1: Experimental layout

n=7
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Harvest 2nd group

assign treatment
1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Figure 2: Monthly plasma glucose concentrations of CON and NR1 cows from d 30 – d 110 of gestation
(trt*day, P = 0.0018)

*Means differ P < 0.05
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Figure 3: (A) Plasma glucose, (B) serum triglycerides, and (C) serum cholesterol concentrations from
control and nutrient restricted fetuses and dams1 at d 110 of gestation
a,b
Means differ P < 0.05

A

B

C

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Figure 4: Monthly plasma glucose concentrations of CON and NR1 cows from d 30 – d 190 of gestation
(trt*day, P = 0.0001)

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
*Means differ between CON and NR/CON; P < 0.05
#Means differ between CON and CON/NR; P < 0.05
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Figure 5: (A) Plasma glucose, (B) serum triglycerides, and (C) serum cholesterol concentrations from control and
nutrient restricted fetuses and dams1 at d 190 of gestation
a,b,c
Means differ P < 0.05
e,f
Means differ P < 0.10

A

B

C

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Figure 6: Adipocyte Diameter (um) of d 190 control and nutrient restricted fetuses1

30
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CON
NR/CON
CON/NR

20
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P = 0.15
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0
1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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CHAPTER III
Effects of maternal nutrient restriction during early or mid-gestation
on miRNA expression in the bovine cotyledon

ABSTRACT
Primiparous Angus-cross cows (n = 38) were synchronized and artificially
inseminated with semen from a single Angus sire. Animals were fed at 1.3 x (Control
[CON]) or 0.55 x (Nutrient Restricted [NR]) of maintenance energy and crude protein
requirements based on BW (NRC 1996). Animals were blocked by BCS and BW and
assigned to treatments. A subset of animals (n = 16) was fed either NR (n = 8) or C (n =
8) from d 30-110 of gestation. The remaining animals (n = 22) were fed CON (n = 8) d
30-190; NR (n = 7) d 30-110 followed by CON d 110-190; or CON (n = 7) d 30-110
followed by NR d 110-190. Cows were sacrificed on d 110 or d 190 of gestation and the
fetus and placenta collected. RNA was isolated from flash frozen cotyledon samples (3
subsamples/treatment) using the mirVana microRNA Isolation kit and analyzed using a
previously validated microarray. MicroRNA expression was analyzed as an ANOVA
analysis using appropriate procedures correcting for false discovery rate of microarray
data. Of the sequences chosen for microarray, 88 showed significant (P < 0.05)
differential expression between d 190 treatment groups. A total of 40 miRNAs were
upregulated in the control group compared with both nutrient restricted groups and a total
of 26 miRNAs were upregulated in the nutrient restricted groups compared with the
control group. In d 110 animals, 142 showed significant (P < 0.05) differential expression
between control and nutrient restricted groups. A total of 51 were upregulated in the
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control group versus the nutrient restricted group and a total of 91 miRNAs were
upregulated in the nutrient restricted group versus the control group. In a comparison of d
110 and d 190 control animals, 139 sequences were (P < 0.05) differentially. A total of
57 miRNAs were upregulated for d 110 control fetuses and 82 miRNAs were upregulated
for d 190 control fetuses. Of the 157 individual miRNAs, only 33 were available in
TargetScan or picTar for predicted target analysis. Top KEGG pathway analysis
included: Axon guidance, endocytosis, neuroactive ligand receptor interaction, MAPK
signaling pathway, and spliceosomes. The data show that maternal nutrient restriction
during early or mid gestation causes asymmetrical fetal growth restriction and affects
miRNA regulation differently depending on whether or not the restriction is preceded or
followed by a non-restriction period.

Keywords: Undernutrition, miRNA, cotyledons
INTRODUCTION
MicroRNAs are small, noncoding RNAs that are 20-25 nucleotides long.
MicroRNAs regulate posttranscriptional gene expression by binding to the 3’
untranslated region of their target RNAs, generally messenger RNA (Bartel et al., 2004).
Changes in gene expression can alter how nutrients are transported across cell
membranes and even from the dam to the fetus during gestation (Constancia et al., 2002;
Reik et al., 2003). It is suggested that poor nutrition during gestation may detrimentally
alter postnatal function through changes in DNA methylation (Rakyan et al., 2001).
mRNAs are regulated by miRNAs, which regulate cellular events including: stem cell
differentiation (Houbaviy et al., 2003; Chen et al., 2010;), organ development/formation
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(Boettger et al., 2012; , Cochella et al., 2012), aging (Inukai et al., 2012), cancer cell
growth and metastasis (Schickel et al., 2008; Lages et al., 2012), genetic disease,
cardiovascular diseases (Latronico et al., 2009; Henrion-Caude et al., 2012; Santovito et
al., 2012), and metabolic disorders (Rottiers et al., 2012; Rayner et al., 2014). The
objective of this study was to determine the alteration of miRNA expression in the
cotyledon caused by maternal nutrient restriction during early (d 30 – d 110) or
midgestation (d 110 – d 190) and which molecular pathways would subsequently be
affected in the fetus.
MATERIALS AND METHODS
All animal procedures were approved by Clemson University Animal Care and
Use Committee (AUP #2013-062).

Animals and Sample Collection
Primiparous Angus-cross cows (n = 38) were used to produce the fetuses studied
here. The protocol for the nutrient restriction of these dams was identical to that
described by Taylor et al. (2015). Briefly, cattle were synchronized, artificially
inseminated, and blocked into treatment group by BCS on d 30 of pregnancy. Throughout
the experiment, all animals were fed a TMR (30% soybean hulls, 20% cottonseed hulls,
17.5% peanut hulls, 17% corn screening, 12.5% corn gluten feed, 1.5% salt, 0.5%
calcium, 0.5% trace mineral, 0.5% vitamin premix: 0.65 Mcal NEm/lb, 8.9% CP) at one
of two levels. Diets were fed at either 1.3 x (Control [CON]) or 0.55 x (Nutrient restricted
[NR]) of maintenance energy and crude protein values based on BW (NRC 2000). A
subset of animals (n = 16) was fed either NR (n = 8) or CON (n = 8) from d 30-110 of
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gestation. The remaining animals (n = 22) were fed CON (n = 8) d 30-190; NR (n = 7) d
30-110 followed by CON d 110-190; or CON (n = 7) d 30-110 followed by NR d 110190. Cattle were maintained together on a dry lot with free access to water and were fed
individually once daily in the morning. Animal BW was taken every wk and used to
reformulate rations throughout the experiment and BCS was collected every other week.
All animals were harvested at the same commercial plant. Fetal weight, empty
fetal weight, crown rump length, abdominal and thoracic circumference were measured
and recorded for each fetus. All placentomes from each cow were counted and greatest
and least diameter of each at the fetal-maternal interface was recorded. The average
diameter of each placentome was used to calculate placentomal surface area of each
individual placentome, total placentomal surface area, and average surface area per
placentome. Placentomes were then divided into cotyledonary and caruncular tissue,
separated by tissue type, and total caruncular and total cotyledonary tissue weights were
recorded. The tissue weights were used to calculate the ratio of fetal and maternal
contribution to placentome. Samples of cotyledonary and caruncular tissue were collected
into 2 mL CryoELITE tubes (Wheaton, Millville, NJ) and flash frozen in liquid Nitrogen.
The samples were stored at -80° C for further analysis.

RNA Isolation
Isolation of RNA was performed from randomly selected animals representing
three animals per treatment group using flash frozen cotyledon samples of both d 190 and
d 110 fetuses. Total RNA fractions were isolated using the mirVana microRNA Isolation
kit (ThermoScientific, Waltham, MA) following manufacturer’s recommendations. RNA
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quantity as well as 260/280 nm ratios were determined on a Nanodrop 1000
spectrophotometer (ThermoScientific, Waltham, MA). Additionally, the integrity of the
total RNA samples were measured using the Agilent RNA 6000 Nano Kit (Agilent
Technologies, Santa Clara, CA) in a 2100 Bioanalyzer (Agilent Technolgies, Santa Clara,
CA) where RNA quality was evaluated by RNA integrity number calculated with the
Agilent 2100 expert software.

Microarray
Three RNA samples per treatment group were submitted for sequencing to LC
Science’s Microarray services (Houston, TX). To compare miRNA expression between
treatment groups, a microarray was custom designed and conducted by LC Science’s
Microarray services (Houston, TX). The custom array was designed based on sequencing
results and also included all reported Bos taurus miRNA (Stowe et al., 2014; Hagen et
al., 2015, in press).

Statistics and Analysis
For d 110 animals, BW and BCS change was analyzed as an ANOVA analysis
using the GLM procedure of SAS. Fetal weights and measurements were analyzed using
the MIXED procedure of SAS with treatment, sex, and their interaction in the model
statement. For d 190 animals, Maternal BW and BCS changes and fetal
weights/measurements were, analyzed as an ANOVA analysis using the GLM procedure
of SAS. A tendency was defined as P < 0.10 and a significance difference was defined as
P < 0.05
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An ANOVA test was conducted to compare normalized expression levels
between treatment groups. In order to determine functional differences in expressed
miRNAs among CON and NR cotyledon tissue, their target genes were extracted using
two independent target prediction tools: TargetScan (Lewis et al., 2005) and picTar (Krek
et al., 2005). The Database for Annotation, Visualization and Integrated Discovery
(DAVID v. 6.7; http://david.abcc.ncifcrf.gov; (Dennis et al., 2003; Huang da et al.,
2009)) is a free online bioinformatics resource that provides interpretation of biological
themes associated with large gene lists. DAVID was used to annotate predicted target
genes of differentially expressed miRNAs and to identify significant functional
enrichment in the miRNA gene targets relative to the whole genome background. After
identifying function enrichment, gene targets were analyzed using Kyoto Encyclopedia of
Genes and Genomes (KEGG), a database used for identifying functions and utilities
based on molecular –level information (Kanehisa et al., 2000).

RESULTS
Maternal BW and BCS change (Table 1) showed that d 110 NR cows had
decreased BW (P < 0.0001) and BCS (P < 0.0001) from d 30 – d 110 compared with d
110 CON cattle. In d 190 animals, NR/CON cattle had a decrease in both BW (P <
0.0001) and BCS (P = 0.0008) from d 30 – d 114 when compared with CON/NR and
CON cattle. A decrease in BW (P < 0.0001) and BCS (P < 0.0001) was observed in
CON/NR animals from d 114 – d 190 compared with NR/CON and CON cattle. Fetal
size and weights at d 110 of gestation are shown in Table 2. Fetal weights and empty fetal
weights were reduced (P = 0.0027, P = 0.0023, respectively) in the NR fetuses versus
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CON fetuses. Crown rump length and abdominal circumference was unaffected (P =
0.0110, P = 0.0265, respectively), while thoracic circumference was reduced in NR
fetuses versus CON fetuses (P = 0.0002). Fetal size and weights are shown in Table 2.
Fetal weights tended to be reduced (P = 0.07) in NR/CON and CON/NR versus.
CON/CON cattle and empty fetal weights were reduced (P = 0.03) in NR/CON and
CON/NR versus. CON/CON cattle. Abdominal and thoracic circumference was reduced
(P = 0.01, P = 0.03, respectively) in NR/CON and CON/NR fetuses versus. CON/CON
fetuses, but crown rump length was unaffected (P = 0.32) (Taylor et al., 2015).
A total of 2,931 miRNA sequences were probed for based on sequencing results
and including all reported bovine miRNA. The probes were custom designed and have
been previously used in bovine studies (Stowe et al., 2014). Of the sequences chosen for
microarray, 88 showed differential expression (P < 0.05) between d 190 treatments
(Table 3), 39 of which were at low signal (detected signal intensity <500, based on a
range from 1 to over 65,000) (Supplemental Table 1). A total of 40 miRNAs were
upregulated (17 at low expression) in the control group compared with both nutrient
restricted groups and a total of 26 miRNAs were upregulated (22 at low expression) in
the nutrient restricted treatments compared with the control group. In d 110 animals, 142
showed differential expression (P < 0.05) between control and nutrient restricted groups
(Table 4), 52 of which were at low signal (Supplemental Table 2). A total of 51 were
upregulated (20 at low expression) in the control group versus the nutrient restricted
group and a total of 91 miRNAs (22 at low expression) were upregulated in the nutrient
restricted group versus the control group. In a comparison of d 110 and d 190 control
animals, 139 sequences were differentially expressed (P < 0.05; Table 5), 50 of which
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were at low signal (Supplemental Table 3). A total of 57 miRNAs were upregulated (21
at low expression) for d 110 control fetuses and 82 miRNAs were upregulated (29 at low
signal) for d 190 control fetuses. After eliminating all duplicates, there were 157 miRNA
sequences remaining that were differentially expressed. Of the 157 miRNAs, 62 did not
map to miRbase (miRbase.org) or the Bos taurus genome, which are most likely not
miRNA and given the number of probes included in the microarray, some may have been
false positives. Of the 62 miRNAs, only 33 were available in TargetScan or picTar for
predicted target analysis. The remaining 33 miRNA were predicted to target a total of
23,988 genes, 5959 of which were duplicated across the target lists (targeted by more
than one miRNA). All duplicated genes were subjected to gene ontology (GO) to
determine which pathways were represented. KEGG pathway analysis of the cotyledon
revealed 116 KEGG pathways. Top ranking pathways included: Axon guidance,
endocytosis, neuroactive ligand receptor interaction, MAPK signaling pathway, and
spliceosomes (Table 6).

DISCUSSION
To our knowledge, this is the first study to evaluate the affect of miRNA
expression within the bovine cotyledon. Previous studies have elucidated miRNA of bull
sperm (Stowe et al., 2014) and bovine fetal back fat (Sun et al., 2014). Despite these
studies, the bovine genome lacks the same level of annotation as the human genome.
While the bovine genome is still lacking literature on elucidating miRNA
expression, work has been done to rectify this gap. In a study aimed at characterizing
bovine miRNA (Jin et al., 2009) samples of 11 different tissues types were collected from
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adult beef cattle, including three subsamples of both the brain and adipose tissue. Of all
the miRNAs identified, it was discovered that very few were tissue specific (miR-9, -124
in brain, miR-122 in liver, miR-1, miR-133a and -206 in muscle) while numerous
miRNAs were only highly expressed in particular tissues (miR-204, -218, and -129-2-3p
in brain tissues, miR-30a, -30e, -30d, -200a and -200b in kidney, miR-192 in liver, miR451 in spleen, miR-21 in spleen and thymus, miR-193b, -378 in LDM muscle). About 15
miRNAs were highly expressed in all 11 tissues sampled and 31 miRNAs were found to
be highly expressed in 8 or more tissues sampled. This broad range of miRNA expression
throughout tissue types suggests that miRNAs play important roles in multiple biological
pathways in the body. Further, the miRNAs expressed from the tissues also were
expressed in three other species (human, mouse, rat), confirming that miRNAs are highly
conserved and suggesting that they have similar biological roles in all species.
There has been some miRNA work done in the human placenta, where miR-141
was involved in trophoblast proliferation (Bentwich et al., 2005) and also has a 3.4x
higher expression rate when the fetuses exhibits IUGR (Tang et al., 2013), which is
supported by the increased expression of miR-141 in nutrient restricted d 110 cotyledons.
Also in the human placenta, Pineles et al. (2007) reported the miR-182 inhibits
trophoblast apoptosis, which works in tandem with miR-141 and its action on trophoblast
proliferation. The upregulation of miR-182 and miR-141 in d 110 nutrient restricted
cotyledons would suggest a coping mechanism from the fetus whereby as maternal
nutrient stress is detected, upregulation of particular genes can possibly decrease the
chances of fetal mortality. However, miR-20b may be involved in inhibition of
angiogenesis (Wang et al., 2012) and this particular miRNA was upregulated in d 110

	
  96	
  

nutrient restricted cotyledons. Therefore, even with a possible increase in capability to
form the trophoblast layer of the placenta, nutrient restriction may potentially decrease
the amount of blood flow available for maternal:fetal exchange. Mir-195 has been
reported to enhance trophoblast migration, invasion, proliferation, and cell survival (Bai
et al., 2012; Xu et al., 2014); this particular miRNA has been significantly downregulated
in women with preeclampsia (Xu et al., 2014). Mir-195 was upregulated in both control d
190 cotyledons verses control d 110 cotyledons, as well as both d 190 nutrient restricted
cotyledons. Preeclampsia is generally caused by abnormal formation of blood vessels into
the placenta (Clark et al., 1998); the upregulation of this miRNA not only suggests a role
in the proper development of the placenta, as well as angiogenesis and vascularization.
Gestational diabetes is correlated with a low expression of miR-29a (Zhao et al., 2011)
and is considered a biomarker for the disease. Cotyledons from d 190 animals restricted
during the second trimester (d 110 – 190) showed an upregulation of miR-29a, which
could indicate that nutrient restriction earlier in gestation may be more susceptible to
gestational diabetes. Mir-335 has been implemented in lipid metabolism and adipocyte
differentiation (Nakanishi et al., 2009) and it was found to be upregulated in d 110
nutrient restricted fetuses compared with d 110 control fetuses. This is in conjunction
with previous studies (Hales and Barker, 2001), that a fetus under nutritional stress
during gestation will alter its endocrine status in order to prepare for postnatal life
(known as the “thrifty phenotype”). Mir-335 was also found to be upregulated in d 190
control fetuses compared with d 110 fetuses, which may indicate higher levels of lipid
metabolism at d 190 of gestation (Nakanishi et al., 2009).
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Undernutrition of ewes during the preconception period and preimplantation
period plays a role in altering miRNA expression in insulin signaling pathways and
hepatic gluconeogenesis in the fetus (Lie et al., 2014a). This study suggested that even if
animals are fed an adequate diet from as early as 7 days of gestation, poor nutrition
leading into the breeding season can have long term detrimental effects on the post natal
animal. Results showed that miRNAs may indirectly alter translation or degradation of
the target transcript or protein (Lie et al., 2014a). Out of the same lab and utilizing a
similar nutrient restriction model, Lie et al. (2014b) showed that undernutrition could also
have a detrimental effect on myogenesis and subsequent glucose metabolism. In the
obese sheep model, altered expression of miRNAs were suggested to influence
myogenesis and adipogenesis in the fetus. Particularly, overexpression of let-7g seemed
to decrease cell proliferation (Kumar et al., 2007; Kumar et al., 2008; Chen et al., 2010).
Fetuses from obese mothers were heavier than control fetuses and had decreased
expression of let-7g, confirming let-7g’s effect on cell proliferation. A sheep study
(Torley et al., 2011) suggests that miRNA are important regulators of gonad
development, including hormone signaling. At time of sex differentiation, increases in
multiple miRNAs suggest that altered expression of miRNAs could lead to incorrect
gonad development.
In conclusion, while there is still work to be done in order to fully extrapolate the
bovine genome, altered nutrition of the dam during early and mid gestation can modify
miRNA expression, subsequently affecting maternal:fetal nutrient transport by decreasing
anigogeneiss and vasculogenesis. However, there does seem to be an enhancing effect of
placenta development by an increase in trophoblast proliferation and a decrease in
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apoptosis, possibly serving as a coping mechanism for those fetuses facing nutrient
restriction. Increased expression of particular miRNA may also be the underlying cause
of the thrifty phenotype, in which the fetus alters its endocrine status in order to better
survive postnatal life.
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Table 1: Maternal BW and BCS change throughout gestation for d 110 and d 190 animals1

d 110 animals
Item

CON

NR

P value

n

8

9

d 30 - 110 BW, kg

11.88 ± 3.33

-53.52 ± 3.14

< 0.0001

d 30 – 110 BCS

0.125 ± 0.169

-1.222 ±0.159

< 0.0001

Item

CON

NR/CON

CON/NR

n

8

7

7

d 30 – 114 BW, kg

11.70 ± 4.36

-50.19 ± 4.66

12.91 ± 4.66

< 0.0001

d 30 – 114 BCS

0.12 ± 0.20

-1.14 ± 0.21

0.00 ± 0.21

0.0008

d 114 – 190 BW, kg

14.48 ± 4.46

19.28 ± 4.77

-77.33 ± 4.77

< 0.0001

d 114 – 190 BCS

-0.06 ± 0.14

0.28 ± 0.15

-1.28 ± 0.15

< 0.0001

d 190 animals

1

P value

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Table 2: Fetal measurements and selected organ weights on d 110 and d 190 of gestation from CON
and NR cows1
Item

CON

NR

P value

d 110
8

8

Fetal wt, kg

n

0.693 ± 0.017

0.600 ± 0.017

0.003

Fetal empty carcass wt, kg

0.531 ± 0.011

0.471 ± 0.011

0.002

Crown rump length, cm

26.56 ± 0.30

25.31 ± 0.30

0.011

Abdominal circumference, cm

20.12 ± 0.78

17.38 ± 0.78

0.027

Thoracic circumference, cm

18.75 ± 0.19

17.31 ± 0.19

0.0002

Item

CON

NR/CON

CON/NR

n

8

7

7

10.34 ± 0.440

009.05 ± 0.470

8.91 ± 0.47

0.08

d 190

Fetal wt, kg
Fetal empty carcass wt, kg

P value

8.50 ± 0.36

007.21 ± 0.390

7.18 ± 0.39

0.03

Crown rump length, cm

65.56 ± 1.440

062.35 ± 1.540

63.5 ± 1.54

0.32

Abdominal circumference, cm

47.25 ± 0.890

043.50 ± 0.960

43.92 ± 0.960

0.02

Thoracic circumference, cm

45.56 ± 0.810

042.71 ± 0.860

42.50 ± 0.860

0.03
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Table 3: Significant differentially expression of miRNA in d 190 CON versus CON/NR versus NR/CON1
d 190
mRNA

CON

NR/CON

CON/NR

P value

n

8

7

7

bta-miR-10b

2640

2023

1553

0.03490

bta-miR-148b

1628

1086

1250

0.01660

bta-miR-15a

949

610

743

0.01920

bta-miR-16a

5367

3916

4662

0.04950

bta-miR-16b

6791

5083

5474

0.04580

bta-miR-181a

1699

1340

983

0.01510

bta-miR-195

2787

1762

1680

0.02720

bta-miR-21-5p

4169

3958

7512

0.00169

bta-miR-22-3p

1023

1113

1367

0.04410

bta-miR-2440

326

541

391

0.02990

bta-miR-2484

283

369

518

0.00939

bta-mir-2904-3-p3

1018

1948

2059

0.03120

bta-mir-2904-3-p5

2778

4635

4941

0.01260

bta-miR-29a

1274

1075

1598

0.00498

bta-miR-30e-5p

10085

9113

7536

0.04540

bta-miR-376d

5294

3210

3424

0.04250

bta-miR-409a

605

480

344

0.01060

bta-miR-410

556

476

392

0.03980

bta-miR-487b

2570

1970

1595

0.02590

bta-mir-658-p3_1ss1TG

422

630

758

0.03860

bta-miR-99b

815

994

748

0.00526

hsa-miR-1260a_R+1_1ss9TG

821

992

569

0.02170

hsa-miR-335-3p

752

469

495

0.02080

hsa-miR-4497_1ss17CA

2434

3302

2285

0.02230

mdo-mir-195

2310

1696

1409

0.00596

mdo-miR-21_L+3

4283

4374

7360

0.00736

mdo-miR-22_1ss21GA

1075

1229

1460

0.01910

mml-miR-1260b_R+1+1ss9AG

1059

1255

716

0.01940

mmu-miR-28c

2347

1641

1638

0.02940

mmu-mir-5105-p3

2744

4533

4969

0.00033

mmu-mir-5105-p3_1ss21TC

2743

4533

4931

0.00050

mmu-mir-5105-p3_1ss24TC

2747

4653

4750

0.00189

mmu-mir-5105-p5_1ss21TC

2793

4432

4957

0.00077

mmu-mir-5105-p5_1ss6GC

285

536

900

0.01400

mmu-mir-5117-p3_1ss19TA

1378

2431

1903

0.00154

mmu-mir-6236-p3_4ss6AG23AG25GC27GA

262

537

456

0.02560

mmu-miR-6243_R-5

1155

1884

1593

0.01890
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oar-miR-382-3p

641

366

351

0.01650

oar-mir-409-3p

1208

1077

837

0.04550

oar-miR-411a-3p

3043

2100

1998

0.02770

oar-miR-411b-3p

466

278

289

0.01500

PC-5p-4028_62

2592

1822

2326

0.02010

sha-miR-181a-5p_L-1R+7

1615

1279

976

0.03100

sha-miR-181a-5p_R+7

1605

1269

1014

0.03900

sha-mir-716a-p3

2075

5198

5981

0.00252

sha-miR-716b

2042

3423

3134

0.04330

sha-mir-716b-p3_1ss4TC

2425

4416

4156

0.02300

sha-mir-716b-p5_1ss3GC

2366

3966

3633

0.04210

ssc-miR-30e-3p

732

618

432

0.03540

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed 0.55 x of
NRC NEm and CP recommendations
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Table 4: Significant differentially expressed miRNA; d 110 CON versus d 110 NR1
d 110
mRNA

CON

NR

n

8

8

bta-miR-99a-5p

1819

1273

0.03460

bta-let-7i

2923

4363

0.01110

bta-miR-106a

1408

2653

0.02260

bta-miR-106a_R+1_1ss1AC

1106

1887

0.03730

bta-miR-1246

3226

1511

0.04050

bta-miR-125b

2678

1747

0.01810

bta-miR-141

869

1917

0.01450

bta-miR-146a

1673

2821

0.01670

bta-miR-146b

1996

3108

0.01680

bta-miR-148b

812

1915

0.02450

bta-miR-151-3p

502

770

0.04370

bta-miR-151-5p

2426

4603

0.01470

bta-miR-15a

563

854

0.04480

bta-miR-15b

2254

5204

0.00246

bta-miR-16a

3647

5745

0.01940

bta-miR-17-5p

1067

1893

0.02410

bta-miR-1777a

6228

3770

0.04230

bta-miR-181c

571

807

0.04990

bta-miR-182

500

783

0.00732

bta-miR-183

245

456

0.00915

bta-miR-185

354

640

0.01730

bta-miR-186

2193

3423

0.03680

bta-miR-191

4637

7077

0.02430

bta-miR-20a

980

1765

0.03190

bta-miR-2284x

256

489

0.00694

bta-miR-2391

3173

199

0.00652

bta-miR-23a

7896

10641

0.02820

bta-miR-23b-3p

8779

11978

0.02890

bta-miR-2440

538

226

0.00377

bta-miR-2487_L-2R-3_1ss15CT

2348

686

0.00840

bta-mir-2887-2-p3

2411

970

0.02380

bta-mir-2904-3-p3

3033

1330

0.03510

bta-miR-335

5988

8450

0.04370

bta-miR-369-3p

1426

904

0.03970

bta-miR-377

303

661

0.02820

bta-miR-378

1736

2846

0.04120

bta-miR-378b

700

1297

0.04490
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P value

bta-miR-378c

700

1310

0.00248

bta-miR-378c_R+1+1ss21TG

800

1445

0.00035

bta-miR-411c-5p

412

720

0.03460

bta-miR-421

671

1145

0.01260

bta-miR-424-3p

583

764

0.03170

bta-miR-425-5p

584

1243

0.02970

bta-miR-432

2054

2742

0.02840

bta-miR-450b

2084

3199

0.02950

bta-miR-451

1532

3015

0.04740

bta-miR-495

1504

3680

0.04040

bta-miR-503-5p

2349

4314

0.03080

bta-miR-532

215

428

0.02510

bta-miR-574

647

358

0.04510

bta-miR-6119-5p

1086

1788

0.02530

cfa-miR-203

2123

4060

0.02090

cgr-miR-1973_L+5R+6

3116

1511

0.01020

ggo-miR-574_1ss22AT

3244

1054

0.02910

hsa-miR-151b_R+5

1670

3221

0.01060

hsa-miR-378d

751

1319

0.00272

hsa-miR-151b_R+3

2403

4338

0.02670

hsa-miR-4324_L-1R-1_1ss16CT

2265

1487

0.04010

hsa-mir-4485-p5_1ss18CT

750

348

0.00114

mdo-miR-22_1ss21GT

957

1331

0.03680

12343

17646

0.01890

mml-miR-378d_1ss21CA

679

1244

0.00251

mml-miR-378d_R-1_1ss21CA

717

1335

0.00209

mmu-let-7j

2376

3586

0.02790

mmu-miR-146a-5p_L+1R+1_1ss19GA

1546

2584

0.02850

mmu-miR-1983

886

1577

0.01890

mmu-miR-378c

781

1436

0.01040

mmu-mir-5105-p3

6651

3139

0.02260

mmu-mir-5105-p3_1ss21TC

6547

3082

0.02150

mmu-mir-5105-p3_1ss24TC

6848

3013

0.02810

mmu-mir-5105-p5_1ss21TC

6322

3153

0.01760

mmu-mir-5109-p3

4360

1651

0.00320

mmu-mir-5109-p3_1ss5TG

3352

816

0.00084

mmu-mir-5109-p5_1ss11TG

1866

533

0.00204

mmu-mir-6236-p3_4ss6AG23AG25GC27GA

615

289

0.01740

mmu-mir-6236-p5

1828

436

0.04890

oar-miR-411a-3p

1882

2490

0.02610

PC-3p-21250_6

1742

3078

0.02460

PC-5p-12650_12

1909

1071

0.04310

PC-5p-80741_1

2351

995

0.04760

mdo-miR-26_R+3
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PC-5p-93007_1

473

890

0.01800

sha-miR-125a_L-6R+2

808

260

0.03670

sha-mir-716a-p3

7859

2609

0.03530

sha-miR-716b

5540

2597

0.02820

sha-mir-716b-p3_1ss4TC

6912

3143

0.01530

sha-mir-716b-p5_1ss3GC

6440

3003

0.00523

ssc-mir-1285-p5

14613

7018

0.02980

ssc-miR-340

649

1032

0.03020

sssc-miR-378_L-2R+3

797

1466

0.04070

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Table 5: Significant differentially expressed miRNA for d 190 CON versus d 110 CON1
mRNA

d 190 CON

d 110 CON

P value

n

8

8

hsa-miR-4324_L-1R-1_1ss16CT

1107

2265

0.01860

sha-miR-181a-5p_L-1R+7

1615

849

0.00039

mmu-mir-5109-p3_1ss5TG

957

3352

0.00087

bta-miR-146b_1ss24TG

3274

2028

0.00096

bta-miR-146b

3046

1996

0.00102

cgr-miR-199b_2ss1-TC22TC

554

979

0.00131

sha-mir-125b-p5_1ss23GA

1064

2434

0.00166

sha-mir-716b-p3_1ss4TC

2425

6912

0.02250

mmu-mir-5109-p3

1270

4360

0.00226

oar-miR-411b-3p

466

289

0.00233

sha-mir-716b-p5_1ss3GC

2366

6440

0.00235

bta-miR-99a-5p

604

1819

0.00325

mmu-miR-28c

2347

1310

0.00365

sha-miR-181a-5p_R+7

1605

911

0.00370

bta-miR-2487_L-2R-3_1ss15CT

757

2348

0.00423

mmu-mir-5109-p5_1ss11TG

471

1866

0.00466

ssc-mir-1285-p5

6004

14613

0.00707

bta-mir-2904-3-p3

1018

3033

0.00742

bta-miR-181a

1699

934

0.00749

mmu-let-7j

3207

2376

0.00779

mdo-miR-195

2310

900

0.00822

mmu-mir-5105-p5_1ss21TC

2793

6322

0.00839

bta-miR-574

383

647

0.00848

bta-miR-151-5p

4531

2426

0.00875

hsa-miR-151b_R+5

3178

1670

0.01000

bta-miR-377

693

303

0.01020

bta-miR-146a

2755

1673

0.01040

bta-let-7g

5353

4236

0.01050

cgr-miR-1973_L+5R+6

1910

3116

0.01090

bta-miR-15b

3522

2254

0.01120

ssc-miR-340

1226

649

0.01120

mmu-miR-146a-5p_L+1R+1_1ss19GA

2943

1546

0.01190

oar-miR-382-3p

641

346

0.01260

hsa-mir-4485-p5_1ss18CT

442

750

0.01340

oar-miR-411a-3p

3043

1882

0.01340

oar-miR-379-3p

2839

1891

0.01370

mmu-mir-5105-p5_1ss6GC

285

858

0.01410

PC-5p-80741_1

1436

2351

0.01410
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bta-miR-450b

4096

2084

0.01470

cgr-miR-100-5p_R+5

477

1696

0.01540

bta-miR-125b

1161

2678

0.01610

bta-miR-23b-3p

11702

8779

0.01610

mmu-mir-5117-p3_1ss19TA

1378

2311

0.01630

sha-miR-716b

2042

5540

0.01700

PC-5p-54837_2

287

506

0.01710

hsa-miR-151b_R+3

4374

2403

0.01880

bta-miR-376a

3792

2302

0.01930

bta-miR-2440

326

538

0.02010

bta-miR-411c-5p

783

412

0.02030

PC-3p-21250_6

3128

1742

0.02060

PC-3p-29341_4

2214

4006

0.02210

bta-miR-195

2287

694

0.02270

bta-miR-2404

902

1861

0.02270

sha-mir-716a-p3

2075

7859

0.02330

bta-miR-214

2762

4361

0.02460

bta-mir-2887-2-p3

999

2411

0.02530

mmu-miR-1983

1411

886

0.02560

bta-miR-23a

10914

7896

0.02580

bta-miR-378c

1235

700

0.02600

bta-miR-15a

949

563

0.02640

mmu-mir-5105-p3_1ss21TC

2743

6547

0.02770

mmu-mir-5105-p3

2744

6651

0.02810

mmu-mir-5105-p3-_1ss24TC

2747

6848

0.02950

bta-miR-425-5p

898

584

0.02980

sha-mir-199a-p5_1ss23CA

698

1166

0.03230

bta-miR-451

3149

1532

0.03330

bta-miR-335

8903

5988

0.03340

bta-let-7i

3874

2923

0.03380

bta-miR-181c

1015

571

0.03430

mmu-mir-6240-p5_1ss20GT

1633

3378

0.03450

bta-mir-2904-3-p5

2778

5869

0.03460

bta-miR-30a-5p

11883

9888

0.03560

bta-miR-378c_R+1+1ss21TG

1300

800

0.03600

bta-miR-141

1846

869

0.03600

bta-miR-376d

5294

3202

0.03610

ggo-miR-574_1ss22AT

1148

3244

0.03700

bta-miR-432

2784

2054

0.03720

sha-miR-199a_1ss8TC

2177

3165

0.03790

bta-miR-16b

6791

4485

0.03950

bta-miR-100

563

1450

0.03990

bta-miR-199a-5p

801

1350

4.08E-02
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mmu-miR-6243_R-5

1155

2238

0.04090

mmu-miR-6243_R+3

729

1605

0.04090

PC-5p-4028_62

2592

1352

0.04230

mml-miR-378d_1ss21CA

1037

679

0.04440

cfa-miR-203

3200

2123

0.04530

bta-miR-450a

1482

833

0.04780

bta-miR-17-5p

1470

1067

0.04820

PC-5p-12650_12

1129

1909

0.04880

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
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Table 6: KEGG pathways for 33 significant differentially expressed miRNA
Gene Count

KEGG pathway
ABC transporters,

7

Adherens junction,

2

Adipocytokine signaling pathway,

2

Alzheimer's disease,

5

Amino sugar and nucleotide sugar metabolism,

5

Amyotrophic lateral sclerosis (ALS),

3

Antigen processing and presentation,

2

Apoptosis, Insulin signaling pathway,

2

Apoptosis, Toll-like receptor signaling pathway, Neurotrophin signaling pathway,

2

Axon guidance,

45

Axon guidance, Fc gamma R-mediated phagocytosis, Regulation of actin cytoskeleton,

2

B cell receptor signaling pathway,

2

Basal transcription factors,

4

Basal transcription factors, Huntington's disease,

4

Base excision repair,

4

Biosynthesis of unsaturated fatty acids,

2

Calcium signaling pathway,

6

Cardiac muscle contraction, Aldosterone-regulated sodium reabsorption,

4

Cell adhesion molecules (CAMs),

16

Cell adhesion molecules (CAMs), Adherens junction,

3

Cell adhesion molecules (CAMs), Tight junction, Leukocyte transendothelial migration,

2

Cell cycle,

7

Cell cycle, TGF-beta signaling pathway,

3

Chemokine signaling pathway,

6

Chondroitin sulfate biosynthesis,

4

Chondroitin sulfate biosynthesis, Heparan sulfate biosynthesis,

3

Circadian rhythm,

8

Complement and coagulation cascades,

4

Cysteine and methionine metabolism,

3

Cysteine and methionine metabolism, Selenoamino acid metabolism,

4

Cytokine-cytokine receptor interaction,

9

Cytokine-cytokine receptor interaction, Chemokine signaling pathway,

5

Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway,

7

Cytokine-cytokine receptor interaction, TGF-beta signaling pathway,

7

Dorso-ventral axis formation,

3

ECM-receptor interaction,

3

ECM-receptor interaction, Cell adhesion molecules (CAMs),

2

Endocytosis,

39
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Endocytosis, Fc gamma R-mediated phagocytosis,

5

Endocytosis, Huntington's disease,

2

Endocytosis, Tight junction,

2

ErbB signaling pathway, Calcium signaling pathway, Endocytosis,

2

Ether lipid metabolism,

3

Fatty acid metabolism, PPAR signaling pathway, Adipocytokine signaling pathway,

4

Fc gamma R-mediated phagocytosis,

3

Focal adhesion,

3

Focal adhesion, ECM-receptor interaction,

9

Focal adhesion, ECM-receptor interaction, Pathways in cancer, Small cell lung cancer,

5

Fructose and mannose metabolism,

2

Gap junction, Pathogenic Escherichia coli infection,

3

Glycerolipid metabolism,

2

Glycerolipid metabolism, Glycerophospholipid metabolism, Ether lipid metabolism,

3

Glycerophospholipid metabolism,

7

Glycosphingolipid biosynthesis,

5

Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,

2

Hedgehog signaling pathway,

5

Hedgehog signaling pathway, Pathways in cancer, Basal cell carcinoma,

4

Heparan sulfate biosynthesis,

10

Huntington's disease,

3

Inositol phosphate metabolism, Phosphatidylinositol signaling system,

8

Insulin signaling pathway,

5

Jak-STAT signaling pathway,

7

Keratan sulfate biosynthesis,

2

Lysine degradation,

12

Lysosome,

21

MAPK signaling pathway,

25

Maturity onset diabetes of the young,

3

mTOR signaling pathway,

3

mTOR signaling pathway, Insulin signaling pathway,

3

N-Glycan biosynthesis,

6

Neuroactive ligand-receptor interaction,

26

Neurotrophin signaling pathway,

5

Nicotinate and nicotinamide metabolism,

3

Nitrogen metabolism,

3

NOD-like receptor signaling pathway,

3

Notch signaling pathway,

10

Nucleotide excision repair,

4

O-Glycan biosynthesis,

10

Oocyte meiosis, Wnt signaling pathway,

2

p53 signaling pathway,

9

Pantothenate and CoA biosynthesis,

2
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Pathways in cancer, Acute myeloid leukemia,

2

Pathways in cancer, Pancreatic cancer,

3

Pathways in cancer, Renal cell carcinoma,

6

Pathways in cancer, Small cell lung cancer,

2

Pathways in cancer, Thyroid cancer,

2

PPAR signaling pathway,

2

Proteasome,

4

Purine metabolism,

5

Pyrimidine metabolism,

3

Regulation of actin cytoskeleton,

12

Regulation of autophagy,

3

Regulation of autophagy, mTOR signaling pathway,

2

Renin-angiotensin system,

2

Retinol metabolism,

3

RIG-I-like receptor signaling pathway,

5

RNA degradation,

11

Selenoamino acid metabolism, Aminoacyl-tRNA biosynthesis,

2

SNARE interactions in vesicular transport,

16

Sphingolipid metabolism,

10

Sphingolipid metabolism, Lysosome,

2

Spliceosome,

24

Systemic lupus erythematosus,

2

Terpenoid backbone biosynthesis,

2

TGF-beta signaling pathway,

10

Tight junction,

12

Tight junction, Regulation of actin cytoskeleton, Viral myocarditis,

2

Toll-like receptor signaling pathway, Pathogenic Escherichia coli infection,

2

Ubiquitin mediated proteolysis,

23

Ubiquitin mediated proteolysis, Endocytosis,

3

Ubiquitin mediated proteolysis, Parkinson's disease,

2

Ubiquitin mediated proteolysis, Pathways in cancer, Renal cell carcinoma,

2

Vascular smooth muscle contraction,

6

Vibrio cholerae infection,

4

Viral myocarditis,

2

Wnt signaling pathway,

13
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Supplemental Table 1: Significant differentially expressed miRNA in d 190 CON versus CON/NR versus
NR/CON1 (low signal)2
d 190
mRNA

CON

NR/CON

CON/NR

P value

n

8

7

7

mmu-let-7f-1-3p_1ss22CT

139

208

89

0.00050

bta-mir-2284b-p3_1ss10TA

34

19

26

0.00171

hsa-miR-3653_L+14

21

48

48

0.00215

bta-miR-4286

60

82

51

0.00296

bta-miR-210

46

66

91

0.00442

bta-miR-655

162

109

142

0.00512

ssc-let-7d-3p

296

328

192

0.00760

hsa-miR-4286_R+4

60

75

47

0.00769

bta-miR-2332

88

153

175

0.00850

oar-miR-494-5p_R-1_2ss12GA17AC

54

119

34

0.00882

hsa-miR-3676-5p_L+5R-1

12

13

31

0.00973

bta-mir-3431-p3

257

144

153

0.01050

cgr-miR-93-3p_1ss11TC

89

85

60

0.01500

bta-miR-1247-5p

38

67

29

0.01530

bta-miR-142-5p

94

73

143

0.01730

mmu-miR-3096b-3p_L_13R-1

6

14

26

0.01740

hsa-mir-5100-p3_1ss16TC

138

252

358

0.01770

bta-mir-2284aa-3-p3_1ss5TC

41

22

27

0.01800

bta-miR-3596

22

56

20

0.01930

bta-let-7a-3p

67

32

51

0.02060

bta-miR-2284z

153

92

133

0.02380

bta-miR-2484_R+8

205

274

342

0.02390

bta-miR-105b

52

42

25

0.02430

bta-miR-6120-3p

74

60

49

0.02540

oar-miR-539-3p_L-4R+2

136

68

87

0.02550

bta-mir-342-p5_1ss23GA

29

36

21

0.02720

bta-mir-6529-p3

733

65

45

0.02940

bta-miR-105a

43

36

21

0.03100

bta-miR-149-5p

30

17

18

0.03140

bta-mir-2284-p3_1ss16AT

62

28

32

0.03150

PC-5p-53837_2

287

442

299

0.03240

bta-miR-34a

111

113

181

0.03350

bta-miR-1185

51

32

44

0.03960

mmu-miR-136-3p

230

161

211

0.04080

PC-5p-43323_2

215

244

160

0.04190

bta-miR-362-3p

82

81

150

0.04260

bta-miR-452

361

258

245

0.04650
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bta-miR-669

124

249

226

0.04710

bta-miR-500)1ss23AT

213

291

375

0.04940

1

CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
2

Detected signal intensity <500, based on a range from 1 to over 65,000
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Supplemental Table 2: Significant differentially expressed miRNA; d 110 CON versus 110 NR1 (lowly
expressed)2
d 110
mRNA

CON

NR

P value

bta-miR-2285k

7

27

0.00961

bta-miR-2455

56

15

0.01180

bta-miR-128

229

358

0.01190

bta-miR-3578

80

22

0.01310

PC-3p-6894_28

23

76

0.01450

bta-miR-2430

35

11

0.01550

PC-3p-8217_21

59

118

0.01640

ssc-miR-196b-3p_L+7R-1

50

13

0.01680

bta-miR-499

16

32

0.01680

bta-mir-6529-p3

37

84

0.01690

bta-miR-192

111

172

0.01880

PC-3p-9715_17

49

101

0.01900

bta-miR-6525

40

18

0.02090

PC-5p-38342_3

20

44

0.02100

PC-5p-18625_8

74

159

0.02110

ssc-miR-450c-3p_1ss21GA

142

301

0.02150

bta-miR-2284z

87

181

0.02220

bta-miR-2285g

8

27

0.02230

bta-miR-1271

39

70

0.02320

sha-miR-7

154

309

0.02390

bta-miR-2487

341

72

0.02390

bta-miR-2285c

33

69

0.02450

hsa-miR-10b-3p

17

35

0.02450

bta-miR-2411-3p

313

181

0.02520

bta-miR-2440_R-4

369

134

0.02550

ssc-miR-24-1-5p

20

30

0.02710

bta-miR-130b

80

104

0.02730

bta-miR-1343-3p

37

25

0.02840

bta-miR-6528

261

70

0.02890

ssc-miR-450b-3p

104

191

0.02980

ssc-miR-331-5p

32

40

0.03000

bta-miR-6119-3p_L-1_1ss23AT

53

86

0.03380

bta-miR-2332

218

127

0.03430

mmu-mir-6236-p3

348

68

0.03440

bta-miR-6120-3p

45

82

0.03450

bta-miR-2284aa-4

98

166

0.03910

ssc-miR-28-3p_1ss11TA

272

377

0.03910

bta-miR-2311

147

33

0.04010
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bta-miR-6119-3p

49

79

0.04020

ssc-miR-574_1ss2AG

228

81

0.04040

bta-miR-671

83

25

0.04170

bta-miR-2284y

244

461

0.04180

bta-miR-502b

108

139

0.04240

bta-miR-2374

228

54

0.04280

bta-miR-24

24

33

0.04310

bta-miR-2284h-5p

203

365

0.04340

bta-miR-190a

83

18

0.04380

bta-mir-3431-p3

184

266

0.04620

ssc-miR-148b-5p

19

37

0.04650

PC-5p-25581_4

32

11

0.04650

bta-miR-2449

76

19

0.04680

bta-miR-2904
274
113
0.04700
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
2
Detected signal intensity <500, based on a range from 1 to over 65,000
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Supplemental Table 3: Significant differentially expressed miRNA for d 190 CON versus d 110 CON1 (low
signal)2

mRNA

d 190 CON

d 110 CON

P value

bta-miR-2285e

51

22

0.00061

bta-miR-6525

15

40

0.00208

oan-miR-148-5p_2ss10TA18AC

121

67

0.00389

bta-miR-3596

22

80

0.00445

ssc-miR-450b-3p

255

104

0.00531

hsa-miR-3064-3p

21

47

0.00662

bta-miR-184

179

32

0.00706

ssc-miR-450c-3p_1ss21GA

312

142

0.00826

bta-miR-455-3p

39

111

0.00887

bta-miR-6520_R+3

12

37

0.01150

bta-miR-503-3p

218

271

0.01160

bta-miR-181b

371

231

0.01230

PC-3p-9715_17

79

49

0.01290

bta-miR-2284h-5p

369

203

0.01510

hsa-miR-10b-3p

43

17

0.01530

bta-miR-2332

88

218

0.01590

PC-5p-18625_8

152

74

0.01650

bta-miR-455-3p_1ss22TC

40

107

0.01700

bta-mir-6529-p3

73

37

0.01870

bta-miR-2411-3p

169

313

0.01880

eca-miR-338-5p

49

15

0.01930

PC-3p-6894_28

49

23

0.02010

bta-miR-96

126

86

0.02030

bta-miR-2284x

394

256

0.02060

bta-miR-144_R-3

59

15

0.02190

bta-miR-1343-3p

24

37

0.02210

bta-miR-2284z

153

87

0.02350

bta-miR-499

43

16

0.02560

bta-miR-6123

57

101

0.02600

bta-miR-183

418

245

0.02620

bta-mir-3431-p3

257

184

0.02840

rno-mir-136-p5

61

45

0.03070

hsa-miR-3653_L+14

21

49

0.03140

sha-miR-7

255

154

0.03240

bta-miR-222_R+4

96

203

0.03290

oar-miR-539-3p_L-4R+2

136

62

0.03300

bta-miR-411c-3p

399

218

0.03420

bta-miR-6528

84

261

0.03590
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bta-miR-194

222

164

0.03620

bta-miR-2284aa-4

166

98

0.03640

bta-miR-1247-5p

38

72

0.03760

bta-mir-2284e-p3_1ss16AT

62

28

0.04100

bta-miR-2374

64

228

0.04210

bta-miR-2487

90

341

0.04250

bta-miR-331

309

430

0.04250

bta-miR-6120-3p

74

45

0.04320

cgr-miR-125b-3p

11

51

0.04360

hsa-mir-5100-p3_1ss16TC

138

233

0.04480

bta-miR-568

26

139

0.04620

bta-miR-199b
105
137
0.04930
1
CON = Control cows fed 1.3 x of NRC NEm and CP recommendations. NR = nutrient restricted cows fed
0.55 x of NRC NEm and CP recommendations
2
Detected signal intensity <500, based on a range from 1 to over 65,000
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CHAPTER IV
CONCLUSION

Maternal nutrient restriction (0.55x of NRC recommendations for NEm and CP)
caused intrauterine growth restriction (IUGR) and altered expression of miRNA. While
early gestation nutrient restriction has been shown to cause IUGR and subsequent
decreased growth and higher incidence of metabolic disorders, we were able to show that
nutrient restriction during midgestation caused just as severe IUGR. Further,
realimentation has been shown to alleviate some of the effects of IUGR. However, with
adequate nutrition but no realimentation, it does not seem as though the growth restriction
can be completely overcome and may persist until parturition. Plasma glucose, serum
triglycerides, and serum cholesterol concentrations were all affected by nutrient status,
reflecting both the decreased nutrients available to the dam as well as the decreased
nutrient transport due to decreased placentome growth. The placentomes and its
components are the primary site for nutrient transport and poor nutrition decreases both
the dam and fetus’s ability to fully form placental connections, thereby altering placental
efficiency. The increase of cotyledons, placentome number, and total placentome surface
area in d 110 nutrient restricted cattle are a combination of fetal and maternal response to
poor nutrition. The dam attempts to compensate by increasing the number of placentomes
and the fetus puts more energy into developing cotyledon structures, overall leading to
more surface area available for nutrient transport. However, as the fetus and dam allocate
nutrient resources into building placentome structures, this decreases how many nutrients
are left over for fetal growth and development. The increase of cotyledons and surface
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area of d 110 – d 190 restricted animals again shows how the fetus is attempting to
compensate for decreased nutrients by increasing the area available for nutrient transport.
The decrease of placentome weight and caruncular weight in d 30 – d 110 restricted
fetuses shows that the control diet from d 110 – 190, while not a full realimentation, was
adequate enough for the dam and fetus to relax the allocation of nutrients to placental
connections. Because there are two different models for nutrient transport, the fetal
demand and maternal sensing models, and these models work in different directions,
further work on the placentomes is required to fully elucidate precisely which
mechanisms are causing tissue accretion.
There is little work done in the bovine model for miRNA and particularly
placental expression of miRNA. There have been human placenta studies and as miRNAs
are highly conserved across species, it is possible that their functions are also similar
across species. The particular miRNA expression suggests that, while nutrient restricted
animals are at a disadvantage, there are some coping mechanisms to help placenta
development by increasing expression of miR-141 and miR-182. However, other
miRNAs were responsible for increased adipogenesis in nutrient a restricted fetus, which
works in conjunction with the thrifty phenotype, and also decreases vasculogenesis and
angiogenesis during placental development, decreasing the routes available for maternal
delivery of nutrients to the fetus.
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